Skip to content
AlternativeMed
Close-up of common sage (Salvia officinalis) leaves
Common sage (Salvia officinalis) leaves, the part used for the tea. Illustrative image.

Herbal Teas & Extracts · Herbal tea

Sage Tea

Salvia officinalis L. · also called Common sage, garden sage, culinary sage, salvia and salvia real (Spanish), sauge officinale (French), Echter Salbei (German).

Sage tea is a savoury, caffeine-free drink made by steeping the dried leaves of common garden sage. It is used for sore throats, mouth rinses and heavy sweating in folk medicine. The human trials of sage, on hot flushes, memory and blood sugar, mostly used extracts, tablets or sprays, not tea, and the evidence is low certainty. The main caution is thujone, a natural substance in sage that is toxic to the brain at high intake, so sage tea is not for people with seizure disorders or in pregnancy.

General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made

Get your Sage Tea today. Order now from Amazon and have it delivered to your door.Shop Sage tea on AmazonSupport our free guides: as an Amazon Associate we earn from qualifying purchases.

About Sage Tea

Sage tea is a caffeine-free infusion of the dried leaves of common garden sage (Salvia officinalis). People drink it, and gargle with it, for sore throats, heavy sweating and as a traditional remedy for indigestion. Research is thin and mostly low certainty: small trials of extracts for hot flushes, sprays for sore throat, and capsules for memory, blood sugar and cholesterol. Almost none used tea. The main cautions are thujone, a natural substance in sage that is toxic to the brain at high intake, so people with seizure disorders should avoid it and the EU regulator does not recommend sage in pregnancy, breastfeeding or under 18; and possible additive effects with diabetes medicines.

What it is

Common sage (Salvia officinalis) is a woody Mediterranean herb in the mint family, the same family as rosemary and thyme. The part used is the dried leaf. Steeped in hot water it makes sage tea. The EU herbal monograph lists the dried leaf as a herbal tea for oral use, and the European Medicines Agency (EMA) lists it as a traditional medicine for mild indigestion, excessive sweating, and inflammation of the mouth and throat.

Sage is not from the tea plant (Camellia sinensis), so it does not carry tea's caffeine. A lab analysis of 33 non-Camellia herbal teas found no caffeine in any of them, but it did not name sage in its abstract, so for sage this is indirect.

18 10

Tea, extract, tincture and oil are not the same thing

Sage tea is the leaf steeped in water. Extracts and tablets are concentrated products, tinctures are made with alcohol, and sage essential oil is the distilled oil. They carry different amounts of thujone. In a survey of 108 sage products, teas ranged from none detectable to a high level, and tinctures were far higher. A second survey found a tea recovers only about a third of the thujone that a strong alcohol extract gives.

Almost every trial on this page used a tablet, capsule, spray or rinse, not a cup of tea. The only tea studies are a six-person pilot, a mouth rinse made from sage tea, and a sage tea-thyme-peppermint rinse. Results from an extract cannot be assumed for tea, and the dangers of the oil do not apply to tea in the same way.

70 69 62 44 46 19

Which sage? Garden sage is not the same as clary, Spanish or white sage

Garden sage (Salvia officinalis) is the plant behind the EU monograph and most of the trials here. Spanish sage (Salvia lavandulifolia) has a different oil with less thujone, and some memory trials used it or a mix. Clary sage, white sage and danshen (Salvia miltiorrhiza) are different plants with different chemistry, and results from them do not carry over.

79 77 72

What it is used for and what the research found

Traditional uses are for sore mouths and throats, heavy sweating and indigestion. In small trials, sage extract tablets were linked to fewer menopausal hot flushes, sage sprays eased sore throat pain for a few hours, and sage extract capsules lowered blood sugar and cholesterol in people with type 2 diabetes. Capsules and extracts also improved some memory tests in short trials. All of these are low certainty at best, and none tested sage tea you drink.

Sage mouth rinses lowered plaque bacteria and, in a 12-week trial, plaque and gum scores. For very ill hospice patients a sage tea rinse eased dry mouth a little more than salt water, but it did not beat it overall.

45 26 2 72 44 39

How strong is the research?

Small. The largest hot flush trial has no placebo group, and two of the five hot flush studies have authors at the maker of the fresh-sage product. The diabetes and cholesterol trials all come from Iran. No trial measured outcomes such as heart attacks or diabetes complications, and none lasted more than 4 months. The EU regulator rates sage leaf as traditional use only, meaning it rests on long use, not proof from modern trials.

11 73 34 9 35 18

At a glance

Traditional uses history, not proof

  • A gargle and tea for sore mouths and throats, recorded from ancient Greek medicine onward (EMA assessment report).
  • A traditional remedy for heavy sweating, listed by the EU regulator on the basis of long use only.
  • Folk use for indigestion and bloating, for memory in old European herbals, and to dry up breast milk when weaning (the last has never been tested).

Studied for research

  • Menopausal hot flushes, low certainty (several small trials of sage extract tablets, none of tea)
  • Sore throat, low certainty (sage sprays and lozenges; none of tea)
  • Mouth rinses for plaque, gum redness and dry mouth, low certainty (small trials, including a sage tea rinse that did not beat salt water overall)
  • Memory and attention, low certainty (small trials of extracts and capsules); Alzheimer's disease, low certainty (one 42-person trial)
  • Blood sugar and cholesterol, low certainty (small trials of extract capsules; a six-person tea pilot)
  • Sweating without menopause, premenstrual symptoms and milk supply, insufficient evidence

Main compounds

  • Thujones (alpha and beta), volatile terpenes that are toxic to the brain at high intake
  • Camphor and 1,8-cineole, two more volatile terpenes in the leaf oil
  • Rosmarinic acid and other phenolic acids
  • Carnosic acid and carnosol, antioxidant diterpenes also found in rosemary
  • Flavonoids such as luteolin and apigenin glycosides, and ursolic acid

Common forms

  • Dried leaf steeped in hot water as a tea (the tea itself)
  • Mouth rinses and gargles made from sage tea
  • Tablets and capsules of dried or fresh-leaf extract (concentrated, used in most trials)
  • Liquid extracts and alcohol tinctures (stronger in thujone than tea)
  • Throat sprays and lozenges, some combined with Echinacea
  • Sage essential oil (not for swallowing; EMA judged its benefit-risk balance negative)

Research links: EMA herbal monograph on sage leaf (Salvia officinalis L., folium), 2016 · EMA public statement on sage essential oil (2016 corrected text) · Systematic review and meta-analysis of sage for hot flashes (Moradi, 2023), PubMed record · Research Library · Genes & Biomarkers Library

What it is and its history

Accepted scientific name
Salvia officinalis L.
Naming authority
L.; published in Species Plantarum, page 23 (1753) (GBIF)
Synonyms
GBIF's current list for this accepted name has no true botanical synonyms beyond three names that actually belong to the Spanish sage group: Salvia officinalis var. lavandulifolia (Vahl) Pau, Salvia officinalis f. lavandulifolia (Vahl) O.Bolos & Vigo, and Betonica brachyodonta Klokov (1960). Older books may use 'Salvia officinalis' loosely for several Mediterranean sages.
Common names
Sage (English); Common sage (English); Garden sage (English); Culinary sage (English); Salvia real / salvia / salvia dulce (Spanish); Sauge officinale (French); Echter Salbei / Heilsalbei / Garten-Salbei (German); Salvia domestica (Italian); Salva / salvia (sálvia) (Portuguese); Echte salie (Dutch); Ada cayi (Turkish (transliterated)); Maryamiyya (Arabic: مريمية) (Arabic (transliterated))
Family or group
Lamiaceae (mint family, also called Labiatae; it also holds rosemary, thyme, oregano, lavender, lemon balm and basil)
Classification
Plantae > Tracheophyta > Magnoliopsida > Lamiales > Lamiaceae > Salvia > Salvia officinalis
Native range
Native to the Mediterranean region, especially around the Adriatic Sea according to the EMA assessment report; widely cultivated and naturalised elsewhere. Commercial material comes mainly from south-eastern Europe (EMA report, citing Blumenthal et al. 2000). A review adds that it is naturalised across the world (p29034191).
Habitat
Not verified from a primary botanical source for this file. General knowledge (unverified here): a sun-loving Mediterranean subshrub of dry, well-drained, often rocky ground.
What it looks like
Roots: Not part of the medicinal use of garden sage. (The root is the used part of a different plant, danshen, S. miltiorrhiza.); Stems: A perennial, evergreen subshrub with woody stems (Wikipedia summary; not verified in a primary botanical source).; Leaves: The medicinal part: whole or cut dried leaf, with the European Pharmacopoeia requiring at least 12 ml/kg essential oil for the whole drug and at least 10 ml/kg for the cut drug (EMA assessment report). Leaves are grey-green (Wikipedia summary).; Flowers: Blue to purplish flowers (Wikipedia summary). Flowers are not the standard medicinal part.; Fruit: Not relevant to the medicinal use; not verified.
Cultivation
Not verified from a primary source read. The EMA report states that cultivation in northern Europe dates to medieval times and that sage reached North America in the 17th century.
Harvest and processing
Not verified in detail. Documented in the sources read: sage leaf is dried and marketed whole or cut; oil content varies with source, harvest time and other factors (EMA report); in one study fresh leaf extracts were 2 to 4 times more active in receptor-binding tests than extracts of dried plant (p31196061), and Swiss products use freshly harvested leaf (p21630133, p33615001). Along the stem the thujone proportion falls from top to base while camphor rises (EMA report, citing Langer et al. 1996).
Look-alikes and adulterants
Name: Salvia lavandulifolia Spreng. (Spanish sage); Note: A separate species in GBIF (key 7948017); NCBI files it as a subspecies of S. officinalis (subsp. lavandulifolia, taxid 3110498). Its essential oil is dominated by camphor, 1,8-cineole, camphene and alpha-pinene (p28825692, p24689309) and does not list thujone among its main components. Most of the cholinesterase and 'cognitive oil' work in people uses this oil (p20937617, p12895684, p11926204), not garden sage. Do not assume results carry over between the two.; Name: Salvia sclarea L. (clary sage); Note: A different, ornamental/aromatic sage grown for its oil. Greek wild material was rich in linalyl acetate (19.75-31.05%) and linalool (18.46-30.43%) (p12405762), very unlike garden sage oil. Not the same as sage leaf in the medicines monograph.; Name: Salvia miltiorrhiza Bunge (danshen, redroot sage); Note: A Chinese medicine plant whose ROOT is the used part; its active compounds are tanshinones and salvianolic acids and its research is mainly cardiovascular (p29698387). This is a different herb and should not be mixed with garden sage research.; Name: Salvia apiana Jeps. (white sage); Note: A California chaparral sage used by the Chumash as a calmative, diuretic and cold remedy and burned as a ritual smudge herb (p33890254). Different chemistry from garden sage (a review compares them); not a substitute.; Name: Salvia fruticosa Mill. (Greek or three-lobed sage); Note: Has its own European Pharmacopoeia monograph (three-lobed sage leaf) alongside the S. officinalis monograph (EMA report). Sometimes sold as 'sage'; its oils have been tested for cholinesterase activity too (search results only, not read).; Name: Pineapple sage, Russian sage, sagebrush; Note: 'Sage' in the name does not make a plant a Salvia officinalis: pineapple sage (Salvia elegans) is another Salvia, while Russian sage (Perovskia) and sagebrush (Artemisia) are other genera. Not checked in a source for this file beyond the genus relationship; named only to warn readers about look-alike names.
Sustainability and conservation
Not verified. No IUCN assessment was retrieved. Garden sage is widely grown as a crop.

Photographs

Close-up of common sage (Salvia officinalis) leaves
Common sage (Salvia officinalis) leaves, the part used for the tea. Illustrative image.

Traditional use and history history, not clinical proof

Tradition or eraDocumented useSource
Ancient Egypt, Greece and RomeThe EMA assessment report (citing Blumenthal et al. 2000) says sage was used in ancient Egyptian, Greek and Roman medicine; the Egyptians as a fertility drug, the Greeks to stop the bleeding of wounds, to clean ulcers and sores, for hoarseness and cough, to enhance memory and in gargles for sore mouths and throats. Written mentions are credited to Hippocrates and later herbalists.s-ema-hmpc-salvia-officinalis-folium
Medieval and early-modern European herbalsSage leaf appears in the writings of Paracelsus, Hildegard von Bingen, Lonicerus, Bock and Matthiolus (Madaus 1938, as cited by EMA). Cultivation in northern Europe dates to medieval times. The herbals of Gerard (1633), Culpeper (1653) and Hill credit sage with improving memory.s-ema-hmpc-salvia-officinalis-folium
Greek-Arabic medicine, India (Ayurveda, Siddha, Unani)Traditional Greek use spread to India, where the dried leaf (called Salbia-sefakuss in Hindi) and fluid extract are used in Ayurvedic, Siddha and Unani medicine (EMA report, citing Blumenthal et al. 2000).s-ema-hmpc-salvia-officinalis-folium
Folk medicine across the Middle East and MediterraneanA review lists folk use for seizure, ulcers, gout, rheumatism, inflammation, dizziness, tremor, paralysis, diarrhea and high blood sugar.p29034191
Pharmacognosy handbooks (19th-20th century onward)Described as carminative (eases gas), antispasmodic, antiseptic, astringent and antihidrotic (reduces sweating); used for flatulent dyspepsia, sore throat, inflamed mouth and gums, excessive sweating and stopping milk flow (galactorrhoea) (EMA report, citing Barnes et al. 2007).s-ema-hmpc-salvia-officinalis-folium
Germany: Commission EThe German Commission E approved internal use of sage for dyspeptic (indigestion-type) symptoms and excessive sweating, and external use for inflammation of the mucous membranes of the mouth and throat (EMA report, citing Blumenthal 2000). Not re-checked against the original Commission E text.s-ema-hmpc-salvia-officinalis-folium
European Union: EMA/HMPC (traditional herbal medicine)Sage leaf has an EU herbal monograph (first adopted 2009, revised 20 September 2016, EMA/HMPC/277152/2015) as a traditional herbal medicine for mild indigestion such as heartburn and bloating, for excessive sweating, for inflammation of the mouth or throat, and for minor skin inflammations. The status is 'traditional use' only, meaning it rests on long-standing use and not on proof from modern trials: the committee said the clinical data cannot meet the criteria for well-established use but accepted them as making the traditional use plausible. A periodic review was open for consultation in 2025; its outcome was not checked.s-ema-hmpc-salvia-officinalis-folium
Where the name comes fromThe genus name Salvia is usually explained as coming from the Latin salvus ('safe, healthy') and salvere ('to feel healthy, to heal'), which is where the popular line that sage means 'to save' comes from. This is from Wikipedia only and was NOT verified from a primary source. Pliny the Elder is said to be the first author to describe a plant called Salvia.s-wikipedia-salvia

Traditional use shows how it was used. It does not show that it works or is safe today.

What is inside, and how it may work

What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.

Main compounds

CompoundFamilyWhere it is concentratedActivity studiedLevel of evidence
alpha-Thujone
PubChem 261491
monoterpene ketone (essential oil)Leaf (essential oil); falls from top to base of the plant
10-60% of the essential oil per the EMA report (citing Bradley 2006); 1.17-9.26% in three Italian oils (p33321838). Very variable: some leaves and some sage oils have more 1,8-cineole than thujone.
Blocks (inhibits) GABA-A receptors; in animals this causes excitation and convulsions at high doses and it is the neurotoxic component of concern in sage oil. Rapidly detoxified by liver P450 enzymes (CYP2A6 > CYP3A4 > CYP2B6 in human liver preparations). 27 14 28 49 75 52 65Animal research
beta-Thujone
PubChem 91456
monoterpene ketone (essential oil)Leaf (essential oil)
4-36% of the essential oil per the EMA report (Bradley 2006)
Same GABA-A receptor-blocking action as alpha-thujone in the animal and cell work (both forms are the neurotoxic principle of concern); the metabolism of the two forms differs in detail. 28 49 75 52Animal research
1,8-Cineole (eucalyptol)
PubChem 2758
monoterpene ether (essential oil)Leaf (essential oil); also the main compound in Spanish sage oil
1-15% of the essential oil (EMA report); 8.80-9.86% in three Italian oils (p33321838)
The best single cholinesterase-blocking terpene found in sage-type oils in the lab (IC50 0.06 mg/ml, about the same as the whole Spanish sage oil); also reduced IL-6 and IL-8 release from stimulated human gum cells by more than 50% (cited in the EMA report). 59 13 65 75Laboratory research
Camphor
PubChem 2537
monoterpene ketone (essential oil)Leaf (essential oil)
5-20% of the essential oil (EMA report); 16.16-18.92% in three Italian oils (p33321838). Mostly the (+)-enantiomer (50-70% in S. officinalis per EFSA 2008, cited in the EMA report).
Weak cholinesterase inhibitor in the lab and antagonistic (works against) 1,8-cineole in the combined test (p12895684). Camphor, like thujone, is named in the EMA report as a constituent with toxic effects in high doses. 59 65 75Laboratory research
Borneol
PubChem 64685
bicyclic monoterpene alcohol (essential oil)Leaf (essential oil); proportion rises from top to base of the plant
Present, amount not given in the sources read
Tested as one of eight terpenoids against acetylcholinesterase in the lab; cut IL-6 and IL-8 release in stimulated human gum cells (cited in the EMA report). 59 75Laboratory research
alpha-Pinene
PubChem 6654
monoterpene hydrocarbon (essential oil)Leaf (essential oil)
Present; amount not given in the sources read for S. officinalis
Mild synergy with 1,8-cineole at the acetylcholinesterase enzyme in the lab. 59 13Laboratory research
Camphene
PubChem 6616
monoterpene hydrocarbon (essential oil)Leaf (essential oil)
6.27-8.08% in three Italian oils (p33321838)
No specific activity established in the sources read. 65Laboratory research
beta-Caryophyllene
PubChem 5281515
sesquiterpene (essential oil)Leaf (essential oil)
Listed among the sesquiterpenes by the EMA report; amount not given
Not studied alone in the sources read for sage; its oxide was tested at the cholinesterase enzyme in the lab (mild synergy with 1,8-cineole). 75 59Laboratory research
alpha-Humulene
PubChem 5281520
sesquiterpene (essential oil)Leaf (essential oil)
Listed by the EMA report; amount not given
No specific activity established in the sources read. 75Laboratory research
Viridiflorol
PubChem 11996452
sesquiterpene alcohol (essential oil)Leaf (essential oil and extracts)
Principal oil component in some samples (p17487611)
Isolated from a sage extract but did not activate PPAR-gamma in the reporter test (p20696231). 52 12Laboratory research
Carnosic acid
PubChem 65126
phenolic diterpene (abietane)Leaf
Not given as a percentage for sage in the sources read. It readily oxidises to carnosol (EMA report).
Activated human PPAR-gamma in a cell reporter assay (EC50 19.6 +/- 2.0 microM); a review describes neuroprotective actions in lab and animal models. In rats, bioavailability of pure carnosic acid by mouth was 40.1% (rosemary-sourced). 55 43 17Laboratory research
Carnosol
PubChem 442009
phenolic diterpene lactoneLeaf
About 0.35% of the leaf (EMA report, citing Bradley 2006)
Activated human PPAR-gamma in the lab (EC50 41.2 +/- 5.9 microM). 55 75Laboratory research
Rosmanol
PubChem 13966122
phenolic diterpene lactone (carnosol breakdown product)Leaf
Listed by the EMA report; amount not given
Seen as a rosemary-extract metabolite (glucuronide) in rat gut, liver and plasma; sage also contains it. 75 57Animal research
Rosmarinic acid
PubChem 5281792
caffeic acid dimer (hydroxycinnamic ester)Leaf; most of the 'tea' polyphenol
Up to 3.3% of the leaf (EMA report, citing Bradley 2006)
Anti-inflammatory activity reported in older work (cited by EMA); in a human gum-cell test it was less effective than the volatile oil components at tea-like concentrations. In people drinking rosemary tea it is split to caffeic acid-type metabolites mainly by colon bacteria. 75 3Laboratory research
Ursolic acid
PubChem 64945
pentacyclic triterpene acidLeaf (waxy surface)
Up to 3.5% of the leaf (EMA report)
Main anti-inflammatory component of a chloroform sage extract in a mouse ear-swelling test, reported as about twice as potent as indomethacin (ID50 0.14 vs 0.26 microM/cm2) (cited in the EMA report); low oral bioavailability. 75 29Animal research
Oleanolic acid
PubChem 10494
pentacyclic triterpene acidLeaf
Up to 0.4% (EMA report)
Antibacterial against vancomycin-resistant enterococci in the lab (MIC 8 microg/ml, ursolic acid 4 microg/ml; cited in the EMA report). Did not activate PPAR-gamma in the reporter test (p20696231). 75 12Laboratory research
Luteolin and its glycosides (7-glucoside, 7-glucuronide)
PubChem 5280445
flavoneLeaf
Total flavonoids about 1.1% of the leaf (EMA report). Luteolin glycoside CID: luteolin 7-O-glucoside 5280637 (C21H20O11).
Luteolin-7-O-glucuronide and luteolin-7-O-glucoside were identified as the probable estrogen-receptor-active components in a sub-extract in the lab (EC50 129 and 0.7 microg/mL for the fractions concerned). 54 75Laboratory research
Apigenin
PubChem 5280443
flavoneLeaf
Listed with its glycosides by the EMA report
Weak affinity at the human brain benzodiazepine site (IC50 30 microM versus 0.05 microM for diazepam), as cited by the EMA report from Bradley 2006. 75Laboratory research
Hispidulin
PubChem 5281628
flavone (6-methoxy-apigenin)Leaf
Listed by the EMA report
One of the most active benzodiazepine-site binders from a sage leaf extract in human brain tissue (IC50 1.3 microM), as cited by the EMA report. 75Laboratory research
Methyl rosmarinate and ferulic acidphenolic acid estersAerial parts
Methyl rosmarinate 24.86 mg/100 g and ferulic acid 6.06 mg/100 g in one Egyptian ethanolic extract (p34499963)
Raised uterine weight in young ovariectomized rats (ferulic acid and the whole extract); mimics an estrogen-like action in rats only. No PubChem CID looked up for methyl rosmarinate; ferulic acid not looked up. 58Animal research

Mechanisms, receptors and pathways

Target or pathwayGene or receptorWhat was foundLevel
Acetylcholinesterase (AChE) inhibitionACHESeveral sage preparations block AChE (the enzyme that clears acetylcholine, a memory-related signal) in test tubes. An S. officinalis leaf extract inhibited AChE in a dose-related way (p16205785); the EMA report cites 68% inhibition by an ethanolic extract at 2.5 mg/ml. Spanish sage oil and its main terpene 1,8-cineole are stronger and the oil lowered cholinesterase in rat striatum and hippocampus after 5 days (p11926204). Important caveat: a 66% ethanolic tincture of S. officinalis showed no AChE inhibition at the highest concentration tested (p23670626), so the effect depends on the preparation. In people, memory and mood gains after single doses were seen with S. officinalis leaf, an S. officinalis extract and with Spanish sage oil, but no study measured brain enzyme activity in the volunteers, so the link between enzyme blocking and the human results is an assumption. 31 61 59 50 32 54 65Laboratory research
Butyrylcholinesterase (BChE) inhibitionBCHEAn S. officinalis leaf extract inhibited BChE even more than AChE in the lab (p16205785); one Italian sage oil had a BChE IC50 of 33.13 microg/mL (p33321838). In late-stage Alzheimer's disease BChE takes over much acetylcholine breakdown, which is why this enzyme draws interest, but that point is general background, not shown for sage. 31 65 48Laboratory research
Acetylcholine receptors (muscarinic and nicotinic)CHRM / CHRN receptor familiesEthanolic extracts of three Salvia species were among the most potent at displacing nicotinic and muscarinic ligands from human cerebral cortex membranes (IC50 below 1 mg/ml); accessions of one species varied a lot. A thujone-free fresh-leaf extract also bound muscarinic M3 receptors (IC50 25 microg/ml). Binding does not tell us whether the plant switches the receptor on or off. 68 64Laboratory research
GABA-A receptor: thujone BLOCKS itGABRA/GABRB/GABRG/GABRD subunit familiesalpha-Thujone suppresses GABA currents in rat neurons (reversible) and recombinant receptors, most strongly alpha1-beta2-delta, which suggests tonic (steady background) inhibition is most affected. In mice it causes convulsions that diazepam and phenobarbital relieve. This is a toxic, excitatory mechanism at high doses, the reason thujone is limited in medicines, and is the opposite of a calming action. 27 14 49Animal research
GABA-A and GABA-B receptor binding (extract)GABRA/GABBR familiesA fresh-leaf thujone-free extract displaced 50% of ligand binding at GABA-A (IC50 89 microg/ml) and GABA-B receptors (229 microg/ml). Separately, the EMA report cites a sage leaf extract that bound the human brain benzodiazepine site, with galdosol (IC50 0.8 microM), hispidulin (1.3 microM) and 7-methoxyrosmanol (7.2 microM) the strongest, versus 0.05 microM for diazepam (second-hand through EMA, original not read). Binding alone does not show a calming effect in people. 64 75Laboratory research
PPAR-gamma activation (blood sugar and fat handling, inflammation)PPARGA sage extract (80% ethanol) activated human PPAR-gamma in a cell reporter assay (EC50 33.7 mg/L); carnosic acid (EC50 19.6 microM) and carnosol (41.2 microM) were identified as active principles. In a second study 12-O-methyl carnosic acid and alpha-linolenic acid were active, but viridiflorol, oleanolic acid and the other isolated diterpenes were not. No study shows PPAR-gamma activation in people taking sage, although one placebo-controlled trial reported better glucose and lipids (p24050577). 55 12 34Laboratory research
Estrogen receptor activity (mixed)ESR1 / ESR2Results disagree. The whole 66% tincture was not estrogenic, while an aqueous-ethanolic sub-extract was (EC50 64 microg/mL), traced to luteolin glucuronide/glucoside (p23670626). An ethanolic extract and ferulic acid raised uterine weight and lowered FSH and LH in young ovariectomized rats (p34499963). The finished tincture itself showed no estrogen-like action in the cell test. The plausibility of a direct estrogen effect in women is therefore low-to-uncertain, and the receptor subtype was not stated in the abstracts read. 54 58Laboratory research
Other brain receptors (extract binding)ADRA2A, OPRM1, CHRM3, HTR1A, HTR2B, HTR2C, SLC6A4A thujone-free fresh-leaf extract bound the alpha-2A adrenergic receptor (IC50 15 microg/ml), mu-opioid (20), muscarinic M3 (25) and serotonin 5-HT1A (19) receptors strongly, and 5-HT2B, 5-HT2C and the serotonin transporter moderately; the authors link this to temperature control and mood in menopause. Fresh leaf extracts were 2-4 times more active than dried-plant extracts. Binding assays only, funded work on a branded product. The same extract in the other study (p23670626) did not inhibit serotonin reuptake in a different test. 64 54Laboratory research
Anti-inflammatory signalling in gum cellsIL6, CXCL8 (IL-8)In human gum fibroblasts, sage infusion cut stimulated release of IL-6 and IL-8 by more than 50%; the volatile compounds 1,8-cineole, borneol, camphor and thujone did this, but rosmarinic acid did not at tea-like concentrations (Ehrnhofer-Ressler 2013, as cited in the EMA report; original not read). A sore-throat spray trial supports local use (p16504956). The EMA report adds a mouse ear-swelling result for ursolic acid. 75 26Laboratory research
Antioxidant effects in people (small pilot)SOD1, CAT, HSPA1A (Hsp70)In six women, four weeks of sage tea raised erythrocyte SOD and CAT activity and lymphocyte Hsp70, and improved lipids, with no liver signal. A pilot with no placebo and six participants. 62Human data
Antimicrobial actionsnot applicableThe EMA report lists lab activity of sage oil against bacteria and yeasts and of oleanolic and ursolic acid against resistant enterococci, which fits the traditional gargle use. Lab activity only. 75Laboratory research

Absorption, metabolism and elimination

Absorption
No absorption study of sage tea or sage extract was found by the European regulator (EMA report: no pharmacokinetic studies on extracts were available) and none was found in this search. In a 2018 study, volunteers drank a sage infusion and alpha-thujone was found in their urine only in low amounts, with the highest concentration at 94 ng/L in the volunteer with the highest intake per body weight.
Distribution
No human tissue-distribution data for sage compounds. Rat work on rosemary extract (which shares carnosic acid with sage) found only trace amounts reaching the brain; this was not tested with sage.
Metabolism
Thujone: in human liver preparations CYP2A6 is the main enzyme, then CYP3A4 and to a lesser extent CYP2B6, giving less toxic hydroxy-thujones that are then conjugated, with big differences between species. In the 2018 study, 4-hydroxythujone and 7-hydroxythujone were found in volunteers' urine after sage tea (after the conjugates were split), and 2-hydroxythujone was not.
Elimination
Not established for sage in people beyond the urine findings above.
Bioavailability
Unknown for sage in people. A toxicology review by Pelkonen states that thujone bioavailability and human dose-concentration-effect relationships are the most important gaps. Water gets less out of the leaf than alcohol: one survey found tea recovered about 30% of the thujone that a strong alcohol extract gave.

63 49 28 70 69 25 24 40 20

Isolated compounds versus whole extracts

No single compound explains what sage does, and sage tea is not one uniform product. Water pulls out different compounds, in different amounts, than alcohol: a survey found tea recovered only about a third of the thujone that a strong alcohol extract gave, and teas differed from none detectable to more than 37 mg per litre. The best-studied products for menopause and memory are particular extracts (fresh-leaf ethanol extracts, a combination extract), not tea. Thujone is both active and toxic at high intake, which is why thujone-free extracts exist and are studied separately. Research on isolated carnosic acid, rosmarinic acid or ursolic acid mostly comes from rosemary and cell work and cannot stand in for sage tea.

Nutritional composition

A nutrient table does not apply: sage tea is a flavoured water, and its health-related ingredients are essential-oil terpenes, phenolic acids, diterpenes, triterpenes and flavonoids rather than vitamins or minerals. No vitamin or mineral analysis was read, and none is claimed. Caffeine: sage is not from the tea plant. A lab analysis of 33 non-Camellia herbal teas found no caffeine, theobromine or theophylline, but its abstract does not name sage, so the caffeine-free statement for sage is indirect.

12benefits and uses looked at
82studies and sources checked
Low certaintybest evidence rating found
9lab markers tracked in trials

7 low certainty1 very low certainty4 not enough evidence

What was looked at

The 12 benefits and uses checked for Sage Tea, each with how strong the evidence is. Tap one to open it.

Lab markers tracked in the studies

ADAS-cog score (a thinking test used in Alzheimer's trials)Clinical Dementia Rating, Sum of BoxesSecondary memory (recall of words and pictures after a delay)Working memory and accuracy tasksHot flush score (diary-rated frequency and intensity)Fasting blood glucoseHbA1c (average blood sugar over about 3 months)LDL and total cholesterolThroat pain intensity

What is Sage Tea good for?

The main studied uses and how strong the human evidence is for each. "Low" is the best rating found for any use, and several are lower. Nearly all trials used extracts, capsules, sprays or rinses. Each row says whether tea was involved. Sage tea is not a replacement for medicine.

Memory and attention in healthy adults (sage leaf extracts and capsules, not tea)Low certaintySmall placebo-controlled trials found that sage leaf extracts or capsules improved some memory and attention tests for a few hours, and one 29-day trial of a sage combination extract improved working memory tasks. None of these trials used sage tea. The trials are small and several are linked to the same research group or to a company. Alzheimer's disease, mild to moderate (Salvia officinalis liquid extract)Low certaintyOne small 4-month placebo-controlled trial in Iran found a sage extract slowed the fall in thinking scores more than placebo in people with mild to moderate Alzheimer's disease. No larger trial has repeated it, and sage tea was not tested. Sage is not a proven treatment and should not replace prescribed medicine. Mood and calm in healthy adults (dried sage leaf in capsules)Very low certaintyIn one small crossover trial, dried sage leaf in capsules improved mood scores in healthy young adults, but the calming effect of the lower amount disappeared during a stressful task. This is early and mixed evidence, and not from tea. Sage tea itself for memory, thinking or moodNot enough evidenceWe found no trial of sage tea for memory, thinking or mood. All the human trials above used capsules, drops or standardised extracts. A cup of tea cannot be assumed to do the same. Menopausal hot flushes (sage leaf extract tablets; not tea)Low certaintySeveral small trials of sage leaf extract tablets found fewer or milder hot flushes. Two had a placebo. A pooled review found fewer flushes but the range of possible results was wide, and two of the trials have authors who work for the maker of the fresh-sage tablets. No trial tested sage tea. Excessive sweating (other than menopausal)Not enough evidenceSage tea is a traditional remedy for heavy sweating and EU regulators list it for this, but we found no controlled trial of sage for sweating outside menopause. Sore throat (sage sprays and lozenges; not gargled tea)Low certaintyA 15% sage extract spray eased sore throat pain more than placebo in the first two hours in a trial of 286 people, and a sage and Echinacea spray worked about as well as a chlorhexidine and lidocaine spray in another. The first trial's lead author works for a company, the second used a combination product, and who paid for each is not stated in the abstracts. No trial tested sage tea as a gargle or drink. Mouth rinses: plaque bacteria, gum redness and dry mouth (sage tea or extract rinse, not swallowed)Low certaintySage mouth rinses lowered plaque bacteria in two small trials and, in a 12-week trial of a sage infusion, lowered plaque and gum inflammation scores more than placebo. In very ill hospice patients a sage tea rinse eased dry mouth a little more than salt water but did not beat it overall. Blood sugar in type 2 diabetes (sage leaf extract capsules and tablets)Low certaintyIn three small trials in Iran in people with type 2 diabetes, sage leaf extract lowered blood sugar more than placebo in two, and after-meal sugar in the third. A pooled analysis of the three agrees. All the trials are small, all from Iran, and none used tea. Sage is not a replacement for diabetes treatment. Cholesterol and blood fats (sage leaf extract capsules; one tea pilot)Low certaintyIn small trials from one Iranian group, sage leaf extract capsules lowered total cholesterol, LDL and triglycerides and raised HDL more than placebo. A pooled analysis found lower total cholesterol and LDL but not triglycerides or HDL. A very small pilot of sage tea in six healthy women also reported better cholesterol numbers. Premenstrual syndrome (sage capsules)Not enough evidenceOne triple-blind trial of 90 college students found premenstrual symptoms fell about 20 to 23% over two months with sage capsules, more than with placebo. It is a single small study and no tea was used. Reducing milk supply when weaning (traditional use)Not enough evidenceSage is traditionally used to dry up breast milk, and some people drink sage tea for this. No study has tested whether it works, and there is no safety data for nursing mothers or babies.

Benefits, one by one

Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.

Memory and attention in healthy adults (sage leaf extracts and capsules, not tea)

Low certainty

Small placebo-controlled trials found that sage leaf extracts or capsules improved some memory and attention tests for a few hours, and one 29-day trial of a sage combination extract improved working memory tasks. None of these trials used sage tea. The trials are small and several are linked to the same research group or to a company.

4 studiesLeaf extracts, dried leaf in capsules and a combination extract. No t…

Studies, doses and limits

What the trials found

Scholey 2008 (20 adults over 65, five-way crossover, a standardised Salvia officinalis leaf extract versus placebo): one of the tested amounts improved secondary memory at every test time and accuracy of attention; other amounts helped less. Kennedy 2006 (30 healthy adults, crossover, dried sage leaf in capsules): both amounts improved mood before a stress task, and the higher one improved task performance, while the lower one reduced performance at the later test. Wightman 2021 (94 adults aged 30 to 60, parallel groups, 29 days): a combination extract of Salvia officinalis and Spanish sage (Salvia lavandulifolia) beat placebo on working memory and accuracy tasks, acutely and after 29 days. One author works for the maker of the extract (Nexira), so this is an industry-linked trial, and it used two sage species. Miroddi 2014, a systematic review of eight acute-effect studies, found benefits for thinking in healthy people but warned of method problems and very different preparations.

Results

Several small crossover and parallel trials of extracts point the same way for memory and attention, with short follow-up and no tea trials.

Effect sizes as reported

Not reported as pooled numbers; each trial reported significance on selected tests (for example Scholey 2008 secondary memory at all test times).

Why this rating

Small trials (20 to 94 people), mostly single-session, from related research groups, with different species and products. The only reviewers say the methods need to be better.

Form and dose studied

Leaf extracts, dried leaf in capsules and a combination extract. No trial gave sage as tea. Amounts are not repeated here.

Who was studied

Healthy younger adults, healthy adults over 65 and adults aged 30 to 60.

Limits

Single sessions up to 6 hours in most trials, one 29-day trial, many outcomes tested, one trial industry-linked, nothing tested with tea. Results from extracts cannot be assumed for a cup of tea.

Why researchers looked

Sage has a long reputation in European herbal medicine as a memory herb, and sage extracts block an enzyme (cholinesterase) in test tubes, the same enzyme some Alzheimer's medicines target.

Traditional use

European herbals from the Middle Ages onward credit sage with improving memory.

Proposed mechanism Preliminary mechanism

Test-tube work shows sage extracts can block cholinesterase. No study measured this in people, so it is an idea, not a shown mechanism.

A proposed mechanism does not show that the effect happens in people.

Sage leaf contains thujone, which is toxic at high intake (see the Safety tab). Extracts used in trials are not the same as tea.

61 31 72 42

Alzheimer's disease, mild to moderate (Salvia officinalis liquid extract)

Low certainty

One small 4-month placebo-controlled trial in Iran found a sage extract slowed the fall in thinking scores more than placebo in people with mild to moderate Alzheimer's disease. No larger trial has repeated it, and sage tea was not tested. Sage is not a proven treatment and should not replace prescribed medicine.

3 studiesLiquid extract taken as drops in the trial. Not tea.

Studies, doses and limits

What the trials found

Akhondzadeh 2003 (42 people aged 65 to 80 with mild to moderate Alzheimer's, three centres in Tehran, 16 weeks, a Salvia officinalis liquid extract at a fixed amount versus placebo): at 4 months the sage group did better on the ADAS-cog (F = 4.77, P = 0.03) and the CDR Sum of Boxes (F = 10.84, P < 0.003). Side effects did not differ significantly between groups, except agitation, which appeared more frequent on placebo. The Miroddi 2014 review of sage trials and a 2023 systematic review of natural remedies for Alzheimer's (Ahmad 2023) both list sage among herbs with positive findings. These reviews rest on very few trials.

Results

One 42-person trial with a clear positive result and no replication found in what we read.

Effect sizes as reported

ADAS-cog F = 4.77, P = 0.03; CDR-SB F = 10.84, P < 0.003 (the abstract gives no mean differences).

Why this rating

A single small randomised trial from one group, 4 months long, with no replication; the reviews that mention it are not independent evidence.

Form and dose studied

Liquid extract taken as drops in the trial. Not tea.

Who was studied

Adults aged 65 to 80 with mild to moderate Alzheimer's disease.

Limits

Small, single trial, strength of extract not described in the abstract, 4 months only. Sage should not replace prescribed treatment.

Why researchers looked

Sage extracts block cholinesterase in the lab, which is the target of several approved Alzheimer's medicines.

Traditional use

Sage has long been used in European herbalism for memory.

Proposed mechanism Preliminary mechanism

Cholinesterase blocking seen in test tubes; not shown in the people in the trial.

A proposed mechanism does not show that the effect happens in people.

People with dementia often take several medicines. Ask a doctor or pharmacist before adding sage.

5 42 4

Mood and calm in healthy adults (dried sage leaf in capsules)

Very low certainty

In one small crossover trial, dried sage leaf in capsules improved mood scores in healthy young adults, but the calming effect of the lower amount disappeared during a stressful task. This is early and mixed evidence, and not from tea.

2 studiesDried sage leaf in capsules. Not tea.

Studies, doses and limits

What the trials found

Kennedy 2006 (30 healthy adults, double-blind placebo-controlled crossover, dried sage leaf capsules, mood measured before and after a 20-minute stress task): both amounts improved mood ratings before the task. The lower amount reduced anxiety before the task, but this was abolished by the task, and that amount also reduced alertness during it. The higher amount improved alertness, calmness and contentedness and improved task performance.

Results

Mixed: improved mood before a stressor, not reliably during it.

Effect sizes as reported

Not reported in the abstract.

Why this rating

One small trial of 30 people, a single day per treatment, mixed results by amount and by test.

Form and dose studied

Dried sage leaf in capsules. Not tea.

Who was studied

Healthy young adults.

Limits

One trial, short follow-up, no people with anxiety disorders.

Why researchers looked

The same cholinesterase idea, plus traditional use of sage as a calming herb.

Traditional use

Used traditionally in European herbal medicine for the nerves and memory.

Proposed mechanism Preliminary mechanism

Test-tube work: sage leaf constituents bind to the benzodiazepine site of the brain's GABA-A receptor (Kavvadias 2003). The effect in people is unknown.

A proposed mechanism does not show that the effect happens in people.

Do not combine with sedatives or sleep medicines without asking a pharmacist.

31 30

Sage tea itself for memory, thinking or mood

Not enough evidence

We found no trial of sage tea for memory, thinking or mood. All the human trials above used capsules, drops or standardised extracts. A cup of tea cannot be assumed to do the same.

1 studiesNot applicable.

Studies, doses and limits

What the trials found

No human trial of sage tea for cognition was found. A review of eight acute-effect studies (Miroddi 2014) described a mixture of extracts, essential oil and raw material, with little detail about the products used.

Results

No tea trials.

Why this rating

No studies of tea for this use.

Limits

The gap itself is the finding.

Why researchers looked

Tea is the common way people drink sage.

Traditional use

Sage tea is a traditional drink in Mediterranean and European homes.

Proposed mechanism None

No tea mechanism study was found.

A proposed mechanism does not show that the effect happens in people.

Tea strength varies a lot, including its thujone content (see the Safety tab).

42

Menopausal hot flushes (sage leaf extract tablets; not tea)

Low certainty

Several small trials of sage leaf extract tablets found fewer or milder hot flushes. Two had a placebo. A pooled review found fewer flushes but the range of possible results was wide, and two of the trials have authors who work for the maker of the fresh-sage tablets. No trial tested sage tea.

7 studiesFresh-sage tablets, an ethanol extract and extract tablets. No sage t…

Studies, doses and limits

What the trials found

Bommer 2011 (open trial, no placebo, 71 women with at least five flushes a day, fresh sage leaf tablet for 8 weeks): the intensity-rated flush score fell 50% within 4 weeks and 64% within 8 weeks (P<0.0001), and severe and very severe flushes fell 79% and 100%. Menosan 2021 (80 women aged 48 to 65, double-blind, placebo, 4 weeks, a fresh-sage ethanol extract): the Menopause Rating Scale fell 39.2% and was significantly better than placebo (p = 0.002); the hot flush score fell 55.3%, reaching significance from week 3 (p = 0.028); three adverse events in total, none judged treatment-related. Zeidabadi 2020 (66 postmenopausal women, double-blind, placebo, 3 months, extract tablets): flushing scores fell by 1.6 units. De Leo 1998 (30 women, no placebo, a sage and alfalfa product): flushes and night sweats disappeared in 20 women, but the mix means sage alone cannot be judged. Moradi 2023 (systematic review and meta-analysis, 4 studies, 310 women): all four reported fewer or milder flushes; frequency effect size -1.12 (95% CI -2.37 to 0.14), severity -2.05 (95% CI -6.53 to 2.43) with high heterogeneity.

Results

Four small trials point towards fewer flushes. The pooled interval for frequency just reaches zero and the interval for severity crosses zero.

Effect sizes as reported

Frequency ES -1.12 (95% CI -2.37 to 0.14); severity ES -2.05 (95% CI -6.53 to 2.43) (Moradi 2023). Bommer 2011 flush score down 64% over 8 weeks without a control group.

Why this rating

Small trials of 4 weeks to 3 months. Only two have a placebo. The open trial cannot separate sage from the large placebo effect seen in hot flush trials. The review's pooled range is wide.

Form and dose studied

Fresh-sage tablets, an ethanol extract and extract tablets. No sage tea trial. Amounts are not repeated here.

Who was studied

Postmenopausal and menopausal women with bothersome hot flushes.

Limits

Short trials, self-reported scores, two trials (Bommer 2011 and Menosan 2021) have authors at A.Vogel, the maker of the fresh-sage products, no comparison with hormone therapy, nothing beyond 3 months. Not studied in women who have had breast cancer.

Why researchers looked

Sage is a traditional remedy for sweating and for the changes of the menopause.

Traditional use

EMA records traditional use of sage leaf for excessive sweating.

Proposed mechanism Preliminary mechanism

Lab and rat work suggests plant compounds in sage (such as luteolin glycosides and ferulic acid) have weak estrogen-like activity, but a whole tincture showed none in one cell test. Whether this explains any effect in women is unknown.

A proposed mechanism does not show that the effect happens in people.

Estrogen-like activity seen in the lab: women with hormone-sensitive conditions should ask their doctor first. See the Safety tab.

11 73 74 15 45 54 58

Excessive sweating (other than menopausal)

Not enough evidence

Sage tea is a traditional remedy for heavy sweating and EU regulators list it for this, but we found no controlled trial of sage for sweating outside menopause.

2 studiesNot applicable.

Studies, doses and limits

What the trials found

No controlled trial of sage for sweating without menopause was found. Night sweats were counted alongside hot flushes in the menopause studies, where the abstracts do not separate them in numbers.

Results

Traditional use only.

Why this rating

No trials. The EMA listing rests on long-standing use, not on proof from modern trials.

Limits

Heavy sweating can have medical causes (infection, thyroid problems, diabetes, some medicines) that need a doctor. The EU monograph advises seeing a doctor if sweating does not improve within 6 weeks.

Why researchers looked

A long-standing traditional use.

Traditional use

The EU herbal monograph lists sage leaf, including as a tea, as a traditional herbal medicine for relief of excessive sweating, on the basis of long-standing use only.

Proposed mechanism None

No mechanism established.

A proposed mechanism does not show that the effect happens in people.

See the limits on length of use in the Safety tab.

18 74

Sore throat (sage sprays and lozenges; not gargled tea)

Low certainty

A 15% sage extract spray eased sore throat pain more than placebo in the first two hours in a trial of 286 people, and a sage and Echinacea spray worked about as well as a chlorhexidine and lidocaine spray in another. The first trial's lead author works for a company, the second used a combination product, and who paid for each is not stated in the abstracts. No trial tested sage tea as a gargle or drink.

4 studiesSage fluid-extract spray, Echinacea and sage spray, Echinacea and sag…

Studies, doses and limits

What the trials found

Hubbert 2006 (286 adults with acute viral pharyngitis, double-blind, placebo, adaptive two-stage design, 3 days): the 15% sage fluid-extract spray gave significantly more relief of throat pain over the first two hours after the first use than placebo; the 5% and 30% sprays looked unlikely to beat placebo at the interim check; only minor side effects (dry throat, mild burning). The first author is at the company Sidroga. Schapowal 2009 (154 people aged 12 and over, double-blind, double-dummy): an Echinacea and sage spray had similar response rates to a chlorhexidine and lidocaine spray over three days (63.8% versus 57.8%); Echinacea was in the product, and the abstract does not say who funded it. Weishaupt 2023 (74 people, observational, no control group, Echinacea and sage lozenges): throat pain fell 48% after a single lozenge; in the 18 who tested virus-positive, viral load fell 62% after one lozenge and 96% after 4 days. Sore throats often settle by themselves.

Results

Two controlled trials with positive or equal results (one with a company-affiliated first author, one of a combination product), plus an uncontrolled study whose authors include A.Vogel employees.

Effect sizes as reported

Hubbert 2006: significantly better pain relief than placebo in the first 2 hours (no numbers in the abstract). Schapowal 2009: response rate 63.8% (Echinacea and sage) versus 57.8% (chlorhexidine and lidocaine).

Why this rating

Two controlled trials, one with a company-affiliated first author and one of a combination product, plus an uncontrolled study by the maker; relief measured over short periods; sore throats often improve without treatment.

Form and dose studied

Sage fluid-extract spray, Echinacea and sage spray, Echinacea and sage lozenges. Not tea.

Who was studied

People aged 12 and over with a viral sore throat.

Limits

Short follow-up, no comparison with a plain painkiller or a plain tea gargle, mixed products.

Why researchers looked

Sage has long been used as a gargle and tea for sore mouths and throats, and EMA lists mouth and throat inflammation as a traditional use.

Traditional use

The Greeks used sage in gargles for sore mouths and throats, according to the EMA assessment report.

Proposed mechanism Preliminary mechanism

Sage contains tannins and volatile oils with antiseptic and anti-inflammatory actions in the lab. Their role in a sore throat is not shown.

A proposed mechanism does not show that the effect happens in people.

A sore throat that lasts more than a few days, with high fever, or with trouble swallowing needs a doctor. EMA advises seeing a doctor if mouth or throat symptoms last more than a week.

26 60 71 18

Mouth rinses: plaque bacteria, gum redness and dry mouth (sage tea or extract rinse, not swallowed)

Low certainty

Sage mouth rinses lowered plaque bacteria in two small trials and, in a 12-week trial of a sage infusion, lowered plaque and gum inflammation scores more than placebo. In very ill hospice patients a sage tea rinse eased dry mouth a little more than salt water but did not beat it overall.

4 studiesSage tea-based rinse, 2% infusion rinse, extract mouthwash and a sage…

Studies, doses and limits

What the trials found

Monsen 2021 (88 hospice patients with late-stage cancer, 4 days, a rinse made from sage tea versus saline): overall oral health improved similarly in both groups; dry mouth improved more with sage (p = 0.036 and p = 0.045); the study found no significant overall difference between rinses. Lile 2026 (175 healthy young adults, five groups of 35, a 2% sage infusion rinse three times a day for 12 weeks): plaque and gum inflammation scores fell significantly more than with placebo; chamomile, sage and ginger rinses did not differ from each other, and a chlorhexidine group was also included. Beheshti-Rouy 2015 (70 girls aged 11 to 14, double-blind, 21 days, a sage extract mouthwash): colonies of the bacterium Streptococcus mutans in plaque fell from 3900 to 300 per sample (P = 0.001), against 4400 to 4000 with placebo (not significant). Mutluay Yayla 2016 (60 chemotherapy patients, open-label): a rinse of sage tea, thyme and peppermint with basic mouth care had less grade 1 mouth sores on day 5 (10%) than basic care alone (53.3%); the three-plant mix means sage's own part is unknown.

Results

Encouraging but small trials; bacteria counts are not the same as fewer cavities; the best-controlled trial in very ill patients found no overall difference from salt water.

Effect sizes as reported

S. mutans colonies 3900 to 300 per sample (sage) versus 4400 to 4000 (placebo); grade 1 mouth sores 10% versus 53.3% (mixed rinse, open-label).

Why this rating

Four small randomised trials with short follow-up, different populations and rinse types; one is open-label and uses a mixture.

Form and dose studied

Sage tea-based rinse, 2% infusion rinse, extract mouthwash and a sage-thyme-peppermint hydrosol. All were rinses, not drinks.

Who was studied

Hospice patients, chemotherapy patients, healthy teenagers and young adults.

Limits

No study in people with established gum disease; not compared with fluoride rinses; the newest trial has not been repeated.

Why researchers looked

Gargles and mouth rinses are a very old use of sage tea.

Traditional use

The EU monograph lists sage for inflammations of the mouth and throat.

Proposed mechanism Preliminary mechanism

Antibacterial and anti-inflammatory actions are shown in the lab; effects in the mouth are measured by plaque and gum scores in the trials.

A proposed mechanism does not show that the effect happens in people.

Rinses are spat out. Swallowing sage preparations is a different question (see the Safety tab).

44 39 8 46

Blood sugar in type 2 diabetes (sage leaf extract capsules and tablets)

Low certainty

In three small trials in Iran in people with type 2 diabetes, sage leaf extract lowered blood sugar more than placebo in two, and after-meal sugar in the third. A pooled analysis of the three agrees. All the trials are small, all from Iran, and none used tea. Sage is not a replacement for diabetes treatment.

5 studiesLeaf extract capsules and tablets. Tea was tested only in a six-perso…

Studies, doses and limits

What the trials found

Kianbakht 2013 (80 adults with type 2 diabetes and high blood fats, 3 months): fasting glucose and HbA1c lower than placebo (P = 0.001 and P = 0.01). Behradmanesh 2013 (80 adults with poorly controlled type 2 diabetes, 3 months): 2-hour after-meal glucose lower than placebo (p < 0.05), but no difference in fasting glucose or HbA1c; the authors say higher amounts may be needed. Kianbakht 2016 (100 adults already on glyburide, metformin and atorvastatin, 2 months): fasting and after-meal glucose and HbA1c lower than placebo (P < 0.05). Abdollahi 2023 (meta-analysis of these three trials): fasting glucose lower by 31.15 mg/dL (95% CI -37.56 to -24.73) and HbA1c by 0.94 percentage points (95% CI -1.25 to -0.63). In a small non-randomised pilot of sage tea in six healthy women (Sá 2009), four weeks of tea had no effect on plasma glucose.

Results

Consistent direction in three trials, with large pooled falls; the sage tea pilot found no change in healthy women.

Effect sizes as reported

Fasting glucose -31.15 mg/dL (95% CI -37.56 to -24.73); HbA1c -0.94 points (95% CI -1.25 to -0.63) (Abdollahi 2023, 3 trials).

Why this rating

Three small trials, all from Iran and two from the same group, 2 to 3 months long; one found no change in fasting glucose or HbA1c; no replication elsewhere; no formal grade was found.

Form and dose studied

Leaf extract capsules and tablets. Tea was tested only in a six-person pilot in healthy women.

Who was studied

Adults with type 2 diabetes (trials); six healthy women (tea pilot).

Limits

Short follow-up, no complication outcomes, big effects from small trials deserve caution.

Why researchers looked

Sage has a reputation as an anti-diabetic herb, and sage tea lowered blood sugar in animals.

Traditional use

A review lists folk use of sage for high blood sugar in Middle Eastern and Mediterranean medicine.

Proposed mechanism Preliminary mechanism

Lab work shows sage compounds activate PPAR-gamma, a receptor that affects sugar and fat handling. Not shown in the trials.

A proposed mechanism does not show that the effect happens in people.

May add to diabetes medicines (see the Safety tab).

34 9 35 2 62

Cholesterol and blood fats (sage leaf extract capsules; one tea pilot)

Low certainty

In small trials from one Iranian group, sage leaf extract capsules lowered total cholesterol, LDL and triglycerides and raised HDL more than placebo. A pooled analysis found lower total cholesterol and LDL but not triglycerides or HDL. A very small pilot of sage tea in six healthy women also reported better cholesterol numbers.

5 studiesLeaf extract capsules in trials; tea in the six-person pilot.

Studies, doses and limits

What the trials found

Kianbakht 2011 (67 adults with high cholesterol or triglycerides, 2 months, 34 sage versus 33 placebo): total cholesterol (p < 0.001), triglyceride (p = 0.001), LDL (p = 0.004) and VLDL (p = 0.001) lower and HDL higher (p < 0.001) than placebo; liver enzymes and creatinine did not differ. Kianbakht 2013 and 2016 (80 and 100 adults with type 2 diabetes) found similar lipid changes, in the 2016 trial on top of atorvastatin. Abdollahi 2023 (3 diabetes trials pooled): total cholesterol lower by 43.64 mg/dL (95% CI -83.26 to -4.02), LDL lower, with no significant change in triglycerides or HDL. Sá 2009 (non-randomised pilot, 6 healthy women aged 40 to 50, sage tea for 4 weeks): lower LDL and total cholesterol and higher HDL during and two weeks after the tea, with no liver or other side effects seen. This pilot had no control group and only six people.

Results

Positive in small trials from one region; the tea result comes only from a six-person pilot.

Effect sizes as reported

Total cholesterol -43.64 mg/dL (95% CI -83.26 to -4.02) (Abdollahi 2023); no significant change in triglycerides or HDL in the pooled analysis.

Why this rating

Small trials from one research group, 2 to 3 months, a wide pooled interval, and conflicting triglyceride and HDL results. The tea pilot is very low certainty on its own.

Form and dose studied

Leaf extract capsules in trials; tea in the six-person pilot.

Who was studied

Adults with high blood fats, adults with type 2 diabetes, and six healthy women.

Limits

Cholesterol numbers are stand-in measures, not heart attacks or strokes. No long-term trial.

Why researchers looked

Sage extracts lowered blood fats in animals and may affect fat handling.

Traditional use

Not a traditional use.

Proposed mechanism Preliminary mechanism

PPAR-gamma activation and antioxidant effects are shown in the lab only.

A proposed mechanism does not show that the effect happens in people.

Tell your doctor if you take sage in medicinal amounts alongside a statin.

33 34 35 2 62

Premenstrual syndrome (sage capsules)

Not enough evidence

One triple-blind trial of 90 college students found premenstrual symptoms fell about 20 to 23% over two months with sage capsules, more than with placebo. It is a single small study and no tea was used.

1 studiesCapsules. Not tea.

Studies, doses and limits

What the trials found

Abdnezhad 2019 (90 college students in Tehran, triple-blind, sage capsules versus placebo for 2 months): symptom severity fell 19.84% in month 1 and 23.42% in month 2, and physical and psychological symptoms fell more with sage than with placebo (p < 0.001). The abstract gives no placebo-group numbers.

Results

A single positive trial in young students.

Effect sizes as reported

Symptom severity down 19.84% and 23.42% at months 1 and 2 (sage group).

Why this rating

One small trial, self-reported scores, abstract only, no replication.

Form and dose studied

Capsules. Not tea.

Who was studied

Young women with premenstrual symptoms.

Limits

Nothing beyond 2 months.

Why researchers looked

Sage is used traditionally in women's health.

Traditional use

Traditional use for menstrual and menopausal complaints.

Proposed mechanism None

No mechanism established.

A proposed mechanism does not show that the effect happens in people.

EMA says medicinal use in pregnancy is not recommended; if pregnancy is possible, ask a doctor first.

1

Reducing milk supply when weaning (traditional use)

Not enough evidence

Sage is traditionally used to dry up breast milk, and some people drink sage tea for this. No study has tested whether it works, and there is no safety data for nursing mothers or babies.

2 studiesNot applicable.

Studies, doses and limits

What the trials found

No human study of sage and milk supply was found. The NIH LactMed entry, as we could read it, says no scientific studies on this use were located and no safety data exist for nursing mothers or infants.

Results

Tradition only.

Why this rating

No studies.

Limits

The LactMed text was read through a mirrored copy because the NCBI page was blocked, so wording is not confirmed on the live page.

Why researchers looked

A well-known folk use.

Traditional use

Handbooks describe sage as used for stopping milk flow (galactorrhoea).

Proposed mechanism None

No mechanism established.

A proposed mechanism does not show that the effect happens in people.

Sage could reduce milk when it is not wanted. EMA does not recommend use while breastfeeding.

47 18

Connections to the rest of health

How Sage Tea connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.

Explore every connection: goals, body systems, organs, symptoms, genes

A. Wellness goals

Connected toKind of connectionEvidence statusContextStudies
Blood sugar balance Drug or supplement interaction Low certainty Lowered blood sugar in diabetes trials, so it may add to diabetes medicines.
Preparation or compound: Leaf extract
35 34 2
Hormone balance Drug or supplement interaction Very low certainty Estrogen-like activity in rats and one cell test; not studied in women with hormone-sensitive conditions.
Preparation or compound: Leaf extract
58 54
Memory Support Potential benefit Low certainty Memory and attention in healthy adults (sage leaf extracts and capsules, not tea): Small placebo-controlled trials found that sage leaf extracts or capsules improved some memory and attention tests for a few hours, and one 29-day trial of a sage combination extract improved working memory tasks. None of these trials used sage tea. The trials are small and several are linked to the same research group or to a company. Alzheimer's disease, mild to moderate (Salvia officinalis liquid extract): One small 4-month placebo-controlled trial in Iran found a sage extract slowed the fall in thinking scores more than placebo in people with mild to moderate Alzheimer's disease. No larger trial has repeated it, and sage tea was not tested. Sage is not a proven treatment and should not replace prescribed medicine. 61 31 72 42 5 4
Cognitive Performance Potential benefit Low certainty Memory and attention in healthy adults (sage leaf extracts and capsules, not tea): Small placebo-controlled trials found that sage leaf extracts or capsules improved some memory and attention tests for a few hours, and one 29-day trial of a sage combination extract improved working memory tasks. None of these trials used sage tea. The trials are small and several are linked to the same research group or to a company. Alzheimer's disease, mild to moderate (Salvia officinalis liquid extract): One small 4-month placebo-controlled trial in Iran found a sage extract slowed the fall in thinking scores more than placebo in people with mild to moderate Alzheimer's disease. No larger trial has repeated it, and sage tea was not tested. Sage is not a proven treatment and should not replace prescribed medicine. 61 31 72 42 5 4
Mental Clarity Potential benefit Low certainty Memory and attention in healthy adults (sage leaf extracts and capsules, not tea): Small placebo-controlled trials found that sage leaf extracts or capsules improved some memory and attention tests for a few hours, and one 29-day trial of a sage combination extract improved working memory tasks. None of these trials used sage tea. The trials are small and several are linked to the same research group or to a company. Mood and calm in healthy adults (dried sage leaf in capsules): In one small crossover trial, dried sage leaf in capsules improved mood scores in healthy young adults, but the calming effect of the lower amount disappeared during a stressful task. This is early and mixed evidence, and not from tea. 61 31 72 42 30
Better Focus Potential benefit Low certainty Memory and attention in healthy adults (sage leaf extracts and capsules, not tea): Small placebo-controlled trials found that sage leaf extracts or capsules improved some memory and attention tests for a few hours, and one 29-day trial of a sage combination extract improved working memory tasks. None of these trials used sage tea. The trials are small and several are linked to the same research group or to a company. 61 31 72 42
Brain Health Potential benefit Low certainty Alzheimer's disease, mild to moderate (Salvia officinalis liquid extract): One small 4-month placebo-controlled trial in Iran found a sage extract slowed the fall in thinking scores more than placebo in people with mild to moderate Alzheimer's disease. No larger trial has repeated it, and sage tea was not tested. Sage is not a proven treatment and should not replace prescribed medicine. 5 42 4
Memory Support Traditional use Not enough evidence Sage tea itself for memory, thinking or mood: We found no trial of sage tea for memory, thinking or mood. All the human trials above used capsules, drops or standardised extracts. A cup of tea cannot be assumed to do the same. 42
Cognitive Performance Traditional use Not enough evidence Sage tea itself for memory, thinking or mood: We found no trial of sage tea for memory, thinking or mood. All the human trials above used capsules, drops or standardised extracts. A cup of tea cannot be assumed to do the same. 42
Menopause Support Potential benefit Low certainty Menopausal hot flushes (sage leaf extract tablets; not tea): Several small trials of sage leaf extract tablets found fewer or milder hot flushes. Two had a placebo. A pooled review found fewer flushes but the range of possible results was wide, and two of the trials have authors who work for the maker of the fresh-sage tablets. No trial tested sage tea. 11 73 74 15 45 54 58
Womens Wellness Potential benefit Low certainty Menopausal hot flushes (sage leaf extract tablets; not tea): Several small trials of sage leaf extract tablets found fewer or milder hot flushes. Two had a placebo. A pooled review found fewer flushes but the range of possible results was wide, and two of the trials have authors who work for the maker of the fresh-sage tablets. No trial tested sage tea. Premenstrual syndrome (sage capsules): One triple-blind trial of 90 college students found premenstrual symptoms fell about 20 to 23% over two months with sage capsules, more than with placebo. It is a single small study and no tea was used. 11 73 74 15 45 54 58 1
Hormone Balance Potential benefit Low certainty Menopausal hot flushes (sage leaf extract tablets; not tea): Several small trials of sage leaf extract tablets found fewer or milder hot flushes. Two had a placebo. A pooled review found fewer flushes but the range of possible results was wide, and two of the trials have authors who work for the maker of the fresh-sage tablets. No trial tested sage tea. Premenstrual syndrome (sage capsules): One triple-blind trial of 90 college students found premenstrual symptoms fell about 20 to 23% over two months with sage capsules, more than with placebo. It is a single small study and no tea was used. 11 73 74 15 45 54 58 1
Menopause Support Traditional use Not enough evidence Excessive sweating (other than menopausal): Sage tea is a traditional remedy for heavy sweating and EU regulators list it for this, but we found no controlled trial of sage for sweating outside menopause. 18 74
Healthy Skin Traditional use Not enough evidence Excessive sweating (other than menopausal): Sage tea is a traditional remedy for heavy sweating and EU regulators list it for this, but we found no controlled trial of sage for sweating outside menopause. 18 74
Immune Support Potential benefit Low certainty Sore throat (sage sprays and lozenges; not gargled tea): A 15% sage extract spray eased sore throat pain more than placebo in the first two hours in a trial of 286 people, and a sage and Echinacea spray worked about as well as a chlorhexidine and lidocaine spray in another. The first trial's lead author works for a company, the second used a combination product, and who paid for each is not stated in the abstracts. No trial tested sage tea as a gargle or drink. 26 60 71 18
Inflammation Balance Potential benefit Low certainty Sore throat (sage sprays and lozenges; not gargled tea): A 15% sage extract spray eased sore throat pain more than placebo in the first two hours in a trial of 286 people, and a sage and Echinacea spray worked about as well as a chlorhexidine and lidocaine spray in another. The first trial's lead author works for a company, the second used a combination product, and who paid for each is not stated in the abstracts. No trial tested sage tea as a gargle or drink. 26 60 71 18
Digestive Support Potential benefit Low certainty Mouth rinses: plaque bacteria, gum redness and dry mouth (sage tea or extract rinse, not swallowed): Sage mouth rinses lowered plaque bacteria in two small trials and, in a 12-week trial of a sage infusion, lowered plaque and gum inflammation scores more than placebo. In very ill hospice patients a sage tea rinse eased dry mouth a little more than salt water but did not beat it overall. 44 39 8 46
Healthy Aging Potential benefit Low certainty Mouth rinses: plaque bacteria, gum redness and dry mouth (sage tea or extract rinse, not swallowed): Sage mouth rinses lowered plaque bacteria in two small trials and, in a 12-week trial of a sage infusion, lowered plaque and gum inflammation scores more than placebo. In very ill hospice patients a sage tea rinse eased dry mouth a little more than salt water but did not beat it overall. 44 39 8 46
Blood Sugar Balance Potential benefit Low certainty Blood sugar in type 2 diabetes (sage leaf extract capsules and tablets): In three small trials in Iran in people with type 2 diabetes, sage leaf extract lowered blood sugar more than placebo in two, and after-meal sugar in the third. A pooled analysis of the three agrees. All the trials are small, all from Iran, and none used tea. Sage is not a replacement for diabetes treatment. 34 9 35 2 62
Metabolic Health Potential benefit Low certainty Blood sugar in type 2 diabetes (sage leaf extract capsules and tablets): In three small trials in Iran in people with type 2 diabetes, sage leaf extract lowered blood sugar more than placebo in two, and after-meal sugar in the third. A pooled analysis of the three agrees. All the trials are small, all from Iran, and none used tea. Sage is not a replacement for diabetes treatment. Cholesterol and blood fats (sage leaf extract capsules; one tea pilot): In small trials from one Iranian group, sage leaf extract capsules lowered total cholesterol, LDL and triglycerides and raised HDL more than placebo. A pooled analysis found lower total cholesterol and LDL but not triglycerides or HDL. A very small pilot of sage tea in six healthy women also reported better cholesterol numbers. 34 9 35 2 62 33
Cholesterol Balance Potential benefit Low certainty Cholesterol and blood fats (sage leaf extract capsules; one tea pilot): In small trials from one Iranian group, sage leaf extract capsules lowered total cholesterol, LDL and triglycerides and raised HDL more than placebo. A pooled analysis found lower total cholesterol and LDL but not triglycerides or HDL. A very small pilot of sage tea in six healthy women also reported better cholesterol numbers. 33 34 35 2 62
Heart Health Potential benefit Low certainty Cholesterol and blood fats (sage leaf extract capsules; one tea pilot): In small trials from one Iranian group, sage leaf extract capsules lowered total cholesterol, LDL and triglycerides and raised HDL more than placebo. A pooled analysis found lower total cholesterol and LDL but not triglycerides or HDL. A very small pilot of sage tea in six healthy women also reported better cholesterol numbers. 33 34 35 2 62
Womens Wellness Traditional use Not enough evidence Reducing milk supply when weaning (traditional use): Sage is traditionally used to dry up breast milk, and some people drink sage tea for this. No study has tested whether it works, and there is no safety data for nursing mothers or babies. 47 18

B. Body systems

Connected toKind of connectionEvidence statusContextStudies
Nervous system Contraindication Very low certainty People with epilepsy or past seizures should avoid medicinal sage and oil and ask about tea.
Preparation or compound: Thujone-rich preparations
20 49
Reproductive system Contraindication Very low certainty EMA: use in pregnancy and breastfeeding not recommended. Older sources call thujone able to end a pregnancy, which is unproven in women.
Preparation or compound: Sage leaf (tea, extracts) and especially sage oil
18 20 47
Nervous System Biological association Low certainty Studied for: Memory and attention in healthy adults (sage leaf extracts and capsules, not tea) Studied for: Alzheimer's disease, mild to moderate (Salvia officinalis liquid extract) 61 31 72 42 5 4 30
Reproductive System Biological association Low certainty Studied for: Menopausal hot flushes (sage leaf extract tablets; not tea) Studied for: Premenstrual syndrome (sage capsules) 11 73 74 15 45 54 58 1 47 18
Endocrine System Biological association Low certainty Studied for: Menopausal hot flushes (sage leaf extract tablets; not tea) Studied for: Blood sugar in type 2 diabetes (sage leaf extract capsules and tablets) 11 73 74 15 45 54 58 34 9 35 2 62
Integumentary System Biological association Not enough evidence Studied for: Excessive sweating (other than menopausal) 18 74
Respiratory System Biological association Low certainty Studied for: Sore throat (sage sprays and lozenges; not gargled tea) 26 60 71 18
Immune System Biological association Low certainty Studied for: Sore throat (sage sprays and lozenges; not gargled tea) Studied for: Mouth rinses: plaque bacteria, gum redness and dry mouth (sage tea or extract rinse, not swallowed) 26 60 71 18 44 39 8 46
Digestive System Biological association Low certainty Studied for: Mouth rinses: plaque bacteria, gum redness and dry mouth (sage tea or extract rinse, not swallowed) 44 39 8 46
Cardiovascular System Biological association Low certainty Studied for: Cholesterol and blood fats (sage leaf extract capsules; one tea pilot) 33 34 35 2 62

C. Body parts and organs

Connected toKind of connectionEvidence statusContextStudies
Brain Adverse effect or risk Very low certainty Seizures reported after swallowing sage oil, and after sage tea in one toddler. Thujone blocks GABA-A receptors in lab and animal tests. A safety relationship, not a benefit.
Preparation or compound: Sage oil, strong alcoholic extracts and thujone; rarely tea
19 20 23 56
Liver Biological association Very low certainty Sage tea made carbon-tetrachloride liver injury worse in mice; no human liver cases found.
Preparation or compound: Sage tea (mouse study)
40

I. Biomarkers

Connected toKind of connectionEvidence statusContextStudies
ADAS-cog score (a thinking test used in Alzheimer's trials) Biological association Low certainty Measured in trials: improved versus placebo. A lab change is not the same as a health benefit. 5
Clinical Dementia Rating, Sum of Boxes Biological association Low certainty Measured in trials: improved versus placebo. A lab change is not the same as a health benefit. 5
Secondary memory (recall of words and pictures after a delay) Biological association Low certainty Measured in trials: improved at one tested amount. A lab change is not the same as a health benefit. 61
Working memory and accuracy tasks Biological association Low certainty Measured in trials: improved. A lab change is not the same as a health benefit. 72
Hot flush score (diary-rated frequency and intensity) Biological association Low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 11 73 45
Fasting blood glucose Biological association Low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 2 62
HbA1c (average blood sugar over about 3 months) Biological association Low certainty Measured in trials: lowered in 2 of 3 trials. A lab change is not the same as a health benefit. 2 9
LDL and total cholesterol Biological association Low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 2 33 62
Throat pain intensity Biological association Low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 26 60

J. Genes, receptors and enzymes

Connected toKind of connectionEvidence statusContextStudies
ACHE (acetylcholinesterase) Preliminary mechanism In vitro Inhibited by S. officinalis extract and by Spanish sage oil and 1,8-cineole in enzyme tests; lower brain activity in rats after Spanish sage oil 31 59 50
BCHE (butyrylcholinesterase) Preliminary mechanism In vitro Inhibited, more than AChE, by an S. officinalis leaf extract; an Italian sage oil gave an IC50 of 33.13 microg/mL 31 65
PPARG (PPAR-gamma) Preliminary mechanism In vitro Activated by sage extract, carnosic acid, carnosol and 12-O-methyl carnosic acid in cell reporter assays 55 12
GABA-A receptor (chloride channel) Preliminary mechanism Animal alpha-Thujone blocks it (animal neurons and recombinant receptors); a thujone-free leaf extract competes for ligand binding (IC50 89 microg/ml); flavones and diterpenes bind the benzodiazepine site in brain tissue (cited via EMA) 27 14 64 75
GABA-B receptor Preliminary mechanism In vitro A thujone-free fresh-leaf extract displaced ligand binding (IC50 229 microg/ml) 64
Muscarinic and nicotinic acetylcholine receptors Preliminary mechanism In vitro Ethanolic Salvia extracts displaced ligands from human cortex membranes; extract also bound M3 (IC50 25 microg/ml) 68 64
Estrogen receptor (ER) Preliminary mechanism In vitro Sub-extract active in an ER reporter assay (EC50 64 microg/mL), traced to luteolin glucuronide/glucoside; the whole tincture was inactive; extract and ferulic acid raised uterine weight in rats 54 58
5-HT1A, 5-HT2B, 5-HT2C, serotonin transporter Preliminary mechanism In vitro Extract binding in receptor assays (IC50 19 microg/ml for 5-HT1A; above 32 for the others); no reuptake inhibition in a separate assay 64 54
Alpha-2A adrenergic and mu-opioid receptors Preliminary mechanism In vitro Extract bound both with IC50 about 15 and 20 microg/ml in a binding assay 64
CYP2A6, CYP3A4, CYP2B6 (thujone-metabolising enzymes) Preliminary mechanism In vitro Main human liver enzymes for thujone, in that order of importance 49 28
CYP2D6 Preliminary mechanism In vitro A commercial aqueous sage extract inhibited CYP2D6-mediated dextromethorphan metabolism in vitro (IC50 0.8 mg/ml) 75
IL6 and CXCL8 (interleukin-6 and interleukin-8) Preliminary mechanism In vitro Release from stimulated human gum fibroblasts cut by more than 50% by sage infusion and by 1,8-cineole, borneol, camphor and thujone (as reported in the EMA assessment) 75
SOD1, CAT and HSPA1A (Hsp70) Preliminary mechanism Human Raised erythrocyte SOD and CAT activity and lymphocyte Hsp70 after four weeks of sage tea in six women 62

K. Biological pathways

Connected toKind of connectionEvidence statusContextStudies
Acetylcholine signalling (cholinergic system) Preliminary mechanism In vitro Proposed route for sage's memory and alertness effects; supported by enzyme and receptor assays but not shown in a living human brain 31 61 32 68 5
Thermoregulation and neurotransmitter binding in menopause Preliminary mechanism Human Authors of a binding study propose receptor binding as the route for hot-flush effects; a quantitative EEG change correlated with symptom relief in a randomised trial (sponsor-funded) 64 73 11 45

L. Active compounds

Connected toKind of connectionEvidence statusContextStudies
alpha-Thujone Biological association Animal Blocks (inhibits) GABA-A receptors; in animals this causes excitation and convulsions at high doses and it is the neurotoxic component of concern in sage oil. Rapidly detoxified by liver P450 enzymes (CYP2A6 > CYP3A4 > CYP2B6 in human liver preparations).
Preparation or compound: Leaf (essential oil); falls from top to base of the plant
27 14 28 49 75 52 65
beta-Thujone Biological association Animal Same GABA-A receptor-blocking action as alpha-thujone in the animal and cell work (both forms are the neurotoxic principle of concern); the metabolism of the two forms differs in detail.
Preparation or compound: Leaf (essential oil)
28 49 75 52
1,8-Cineole (eucalyptol) Biological association In vitro The best single cholinesterase-blocking terpene found in sage-type oils in the lab (IC50 0.06 mg/ml, about the same as the whole Spanish sage oil); also reduced IL-6 and IL-8 release from stimulated human gum cells by more than 50% (cited in the EMA report).
Preparation or compound: Leaf (essential oil); also the main compound in Spanish sage oil
59 13 65 75
Camphor Biological association In vitro Weak cholinesterase inhibitor in the lab and antagonistic (works against) 1,8-cineole in the combined test (p12895684). Camphor, like thujone, is named in the EMA report as a constituent with toxic effects in high doses.
Preparation or compound: Leaf (essential oil)
59 65 75
Borneol Biological association In vitro Tested as one of eight terpenoids against acetylcholinesterase in the lab; cut IL-6 and IL-8 release in stimulated human gum cells (cited in the EMA report).
Preparation or compound: Leaf (essential oil); proportion rises from top to base of the plant
59 75
alpha-Pinene Biological association In vitro Mild synergy with 1,8-cineole at the acetylcholinesterase enzyme in the lab.
Preparation or compound: Leaf (essential oil)
59 13
Camphene Biological association In vitro No specific activity established in the sources read.
Preparation or compound: Leaf (essential oil)
65
beta-Caryophyllene Biological association In vitro Not studied alone in the sources read for sage; its oxide was tested at the cholinesterase enzyme in the lab (mild synergy with 1,8-cineole).
Preparation or compound: Leaf (essential oil)
75 59
alpha-Humulene Biological association In vitro No specific activity established in the sources read.
Preparation or compound: Leaf (essential oil)
75
Viridiflorol Biological association In vitro Isolated from a sage extract but did not activate PPAR-gamma in the reporter test (p20696231).
Preparation or compound: Leaf (essential oil and extracts)
52 12
Carnosic acid Biological association In vitro Activated human PPAR-gamma in a cell reporter assay (EC50 19.6 +/- 2.0 microM); a review describes neuroprotective actions in lab and animal models. In rats, bioavailability of pure carnosic acid by mouth was 40.1% (rosemary-sourced).
Preparation or compound: Leaf
55 43 17
Carnosol Biological association In vitro Activated human PPAR-gamma in the lab (EC50 41.2 +/- 5.9 microM).
Preparation or compound: Leaf
55 75
Rosmanol Biological association Animal Seen as a rosemary-extract metabolite (glucuronide) in rat gut, liver and plasma; sage also contains it.
Preparation or compound: Leaf
75 57
Rosmarinic acid Biological association In vitro Anti-inflammatory activity reported in older work (cited by EMA); in a human gum-cell test it was less effective than the volatile oil components at tea-like concentrations. In people drinking rosemary tea it is split to caffeic acid-type metabolites mainly by colon bacteria.
Preparation or compound: Leaf; most of the 'tea' polyphenol
75 3
Ursolic acid Biological association Animal Main anti-inflammatory component of a chloroform sage extract in a mouse ear-swelling test, reported as about twice as potent as indomethacin (ID50 0.14 vs 0.26 microM/cm2) (cited in the EMA report); low oral bioavailability.
Preparation or compound: Leaf (waxy surface)
75 29
Oleanolic acid Biological association In vitro Antibacterial against vancomycin-resistant enterococci in the lab (MIC 8 microg/ml, ursolic acid 4 microg/ml; cited in the EMA report). Did not activate PPAR-gamma in the reporter test (p20696231).
Preparation or compound: Leaf
75 12
Luteolin and its glycosides (7-glucoside, 7-glucuronide) Biological association In vitro Luteolin-7-O-glucuronide and luteolin-7-O-glucoside were identified as the probable estrogen-receptor-active components in a sub-extract in the lab (EC50 129 and 0.7 microg/mL for the fractions concerned).
Preparation or compound: Leaf
54 75
Apigenin Biological association In vitro Weak affinity at the human brain benzodiazepine site (IC50 30 microM versus 0.05 microM for diazepam), as cited by the EMA report from Bradley 2006.
Preparation or compound: Leaf
75
Hispidulin Biological association In vitro One of the most active benzodiazepine-site binders from a sage leaf extract in human brain tissue (IC50 1.3 microM), as cited by the EMA report.
Preparation or compound: Leaf
75
Methyl rosmarinate and ferulic acid Biological association Animal Raised uterine weight in young ovariectomized rats (ferulic acid and the whole extract); mimics an estrogen-like action in rats only. No PubChem CID looked up for methyl rosmarinate; ferulic acid not looked up.
Preparation or compound: Aerial parts
58

Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 25, 2026).

Evidence at a glance: what changed in 4 lab markers

Tap a number to show only those markers. Counts are markers, not people.

The evidence

The research centre for Sage Tea. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.

Evidence by outcome

Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).

How we rate evidence

High certainty

Several well-run trials or reviews agree; further research is unlikely to change the picture much.

Moderate certainty

Good trials point the same way, but some doubt remains.

Low certainty

Small, short or inconsistent trials. The finding could change with better research.

Very low certainty

Very little or very weak human data. Treat as a possibility only.

Mixed findings

Trials or reviews disagree with each other.

Not enough evidence

Not enough human research to say either way.

Evidence against

Good research found no benefit, or found harm.

We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We searched PubMed, downloaded and read the EMA herbal monograph, public statement and the safety sections of the assessment report, and checked plant-name databases. Only abstracts were read for most studies. LactMed, the FDA listing and the German Commission E text were not re-opened for this page and are marked not verified. Certainty ratings are the compiler's own reading, not formal grades, unless a review's own grade is quoted. No study is cited that we could not verify.

Study library: every study we checked 82
StudyDesignPeopleProduct, dose, lengthResult
Abdnezhad 2019
[Salvia officinalis Reduces the Severity of the Premenstrual Syndrome].
Complement Med Res · PMID 30572339 · DOI
Controlled trial
90
College students with premenstrual syndrome (PMS), Tehran, Iran
Sage (Salvia officinalis) capsules
unspecified Not shown here; see the study 2 consecutive months · vs Placebo
Symptom severity fell 19.84% in month 1 and 23.42% in month 2 with sage; physical and psychological symptoms fell more than with placebo (p<0.001).
Severity -19.84% (month 1) and -23.42% (month 2) vs baseline
Methods, limits and funding

Outcomes: PMS symptom severity (questionnaire and daily form)

Limitations: Young students only; self-reported; 2 months; German-language report, abstract only; placebo group's change not given in numbers.

Read: abstract

Abdollahi 2023
The effect of Salvia officinalis on blood glycemic indexes and blood lipid profile in diabetic patients: a systematic review and meta-analysis.
J Complement Integr Med · PMID 35106985 · DOI
Meta-analysis
Adults with diabetes; 3 trials included (total number of people not given in the abstract) Salvia officinalis (leaf extract or tablets)
unspecified Not shown here; see the study Varied · vs Placebo
Fasting glucose MD -31.15 mg/dL (95% CI -37.56 to -24.73); HbA1c MD -0.94 percentage points (-1.25 to -0.63); total cholesterol MD -43.64 mg/dL (-83.26 to -4.02); LDL MD -19.23 mg/dL (-35.81 to -2.65). No significant effect on triglyceride or HDL. No significant effect on liver enzymes; no specific side effects.
Fasting glucose -31.15 mg/dL; HbA1c -0.94 points; LDL -19.23 mg/dL (Fasting glucose -37.56 to -24.73; HbA1c -1.25 to -0.63; total cholesterol -83.26 to -4.02; LDL -35.81 to -2.65)
Methods, limits and funding

Outcomes: Fasting glucose, HbA1c, cholesterol, LDL, triglyceride, HDL, liver enzymes, side effects

Limitations: Only 3 small trials, two from the same group, so the pooled result is not strong evidence; the authors ask for stronger trials. Total participant count not given in the abstract.

Read: abstract

Achour 2021
Bioavailability and nutrikinetics of rosemary tea phenolic compounds in humans
Food Res Int · PMID 33509454 · DOI
Human nutrikinetic study
healthy volunteers Rosemary tea
leaf Not shown here; see the study single ingestion with plasma and urine sampling
Forty-eight compounds found in plasma and urine, nearly all as phase II conjugates. Urinary excretion was 235 micromol, 22.3% of the ingested amount. Rosmarinic acid appears to be split to caffeic acid and 3,4-dihydroxyphenyl-lactic acid in the gut, with strong involvement of colon bacteria.
Methods, limits and funding

Outcomes: Plasma and urine phenolic metabolites

Funding and conflicts: Rosemary tea, not sage tea. The number of volunteers is not given in the abstract.

Read: human

Ahmad 2023
Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials.
Metab Brain Dis · PMID 35960461 · DOI
Systematic review
Randomised trials of natural remedies in Alzheimer's disease (searched to November 2021) Many herbs including Salvia officinalis
unspecified Not shown here; see the study Various · vs Various
Found significant positive effects for several herbs including Salvia officinalis; the review's own conclusions are generous, and its abstract does not give sage-specific numbers.
No pooled numbers in the abstract.
Methods, limits and funding

Outcomes: Alzheimer's disease outcomes

Limitations: Abstract only; sage is one of many herbs; trials appraised with an NIH framework rather than GRADE.

Read: abstract

Akhondzadeh 2003
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.
J Clin Pharm Ther · PMID 12605619 · DOI
Controlled trial
42
Adults aged 65 to 80 with mild to moderate Alzheimer's disease (18 women), three centres in Tehran
Salvia officinalis extract (liquid, taken as drops; extract type and strength not given in the abstract)
unspecified Not shown here; see the study 16 weeks (4 months) · vs Placebo
At 4 months the sage extract group did better than placebo on both measures. No significant difference in side effects except agitation, which looked more frequent on placebo (P = 0.09, not significant).
ADAS-cog F = 4.77, P = 0.03; CDR-SB F = 10.84, P < 0.003. Mean scores and group sizes are not in the abstract.
Methods, limits and funding

Outcomes: ADAS-cog and CDR Sum of Boxes change from baseline; side effects by checklist

Limitations: Small trial (42 people), one research group, 4 months. The abstract does not give the extract strength, group sizes or mean scores, so the size of the benefit cannot be judged here. The agitation finding is not statistically significant. No larger trial has repeated it.

Read: abstract

Al-Ramahi 2013
Use of herbal medicines during pregnancy in a group of Palestinian women.
J Ethnopharmacol · PMID 23933314 · DOI
Other
300
300 women who had just given birth in a Palestinian hospital (survey)
Herbal medicines in pregnancy including sage
leaf Not shown here; see the study During pregnancy · vs Non-users
40% (120 women) used herbs; sage was used by 55% of the herb users. No significant difference in pregnancy outcomes between users and non-users and 99.2% reported no side effects.
Methods, limits and funding

Outcomes: Herb use and pregnancy outcomes

Limitations: Self-reported survey; cannot prove safety; amounts, timing and forms of sage were not measured.

Funding and conflicts: Not stated in abstract

Read: abstract

Arceusz 2013
Comparison of different extraction methods for the determination of α- and β-thujone in sage (Salvia officinalis L.) herbal tea.
J Sep Sci · PMID 23843295 · DOI
Other
Sage herbal tea Sage tea
leaf Not shown here; see the study
Alpha- and beta-thujone and other volatile compounds were found in sage tea; headspace microextraction was most complete.
Methods, limits and funding

Outcomes: Extraction methods for volatile oil compounds

Limitations: Analytical methods paper.

Funding and conflicts: Not stated in abstract

Read: abstract

Beheshti-Rouy 2015
The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial.
Iran J Microbiol · PMID 26668706
Controlled trial
70
Girls aged 11-14 in a dormitory, Hamadan, Iran
Sage (Salvia officinalis) extract mouthwash
unspecified Not shown here; see the study 21 days · vs Placebo mouthwash without active ingredient
Colonies fell from 3,900 to 300 per sample with sage (P=0.001); in the placebo group from 4,400 to 4,000 (not significant).
Plaque S. mutans count about 92% lower with sage (3,900 to 300)
Methods, limits and funding

Outcomes: Streptococcus mutans colony count in plaque samples

Limitations: Counts a bacterium, not tooth decay or gum disease; short (21 days); girls only; the abstract does not give the strength of the rinse.

Read: abstract

Behradmanesh 2013
Effect of Salvia officinalis on diabetic patients.
J Renal Inj Prev · PMID 25340127 · DOI
Controlled trial
80
Adults with type 2 diabetes not well controlled, Shahrekord, Iran
Sage (Salvia officinalis) tablets
unspecified Not shown here; see the study 3 months · vs Placebo tablets
After-meal glucose and cholesterol fell more with sage than placebo (p<0.05). No difference in HbA1c or fasting glucose. The authors suggest higher doses may be needed.
2-hour after-meal glucose and cholesterol lower (p<0.05); fasting glucose and HbA1c not different
Methods, limits and funding

Outcomes: Fasting glucose, 2-hour after-meal glucose, HbA1c, lipids, liver and kidney tests

Limitations: Small; no numbers or confidence intervals in the abstract; dose not stated; 3 months.

Read: abstract

Bi 2016
Investigation of free amino acid, total phenolics, antioxidant activity and purine alkaloids to assess the health properties of non-Camellia tea.
Acta Pharm Sin B · PMID 27006902 · DOI
Lab analysis
lab
33 non-Camellia herbal teas analysed in the lab, including Hibiscus sabdariffa Herbal tea material (including hibiscus sabdariffa)
Not shown here; see the study · vs Camellia teas (green, pu-erh, black)
Caffeine, theobromine and theophylline were not detected in the non-Camellia teas tested. Hibiscus sabdariffa tea was named among teas with high gamma-aminobutyric acid.
Purine alkaloids not detected
Methods, limits and funding

Outcomes: Amino acids, polyphenols, antioxidant activity, purine alkaloids

Limitations: Lab chemistry on dried material; the abstract does not list results for each plant separately, and it does not describe how the hibiscus tea was prepared.

Read: abstract

Bommer 2011
First time proof of sage's tolerability and efficacy in menopausal women with hot flushes.
Adv Ther · PMID 21630133 · DOI
Open label trial
71
Women aged about 56 (mean 56.4) who were at least 12 months past their last period and had at least five hot flushes a day; 69 in the main analysis; 8 practices in Switzerland
Fresh sage leaf tablet (Salvia officinalis)
leaf Not shown here; see the study 8 weeks after a 1-week baseline
Intensity-rated flush score fell 50% by week 4 and 64% by week 8 (P<0.0001). Mild, moderate, severe and very severe flushes fell by 46%, 62%, 79% and 100%. Menopause Rating Scale fell 43%.
Intensity-rated flush score -64% from baseline at 8 weeks (no control group)
Methods, limits and funding

Outcomes: Hot flush diary: intensity-rated flush score (TSIRHF), number per day; Menopause Rating Scale

Limitations: No placebo group, so a placebo response (often large in hot flush trials) cannot be separated; open label; funded and run by the maker of the fresh sage product (author affiliation A. Vogel Bioforce); small.

Funding and conflicts: Authors affiliated with the manufacturer (A. Vogel Bioforce AG).

Read: abstract

Christensen 2010
Activation of the nuclear receptor PPARγ by metabolites isolated from sage (Salvia officinalis L.)
J Ethnopharmacol · PMID 20696231 · DOI
Laboratory study (cell reporter assay)
human PPAR-gamma ligand-binding domain in a reporter cell assay Dichloromethane extract of sage and compounds isolated from it
leaf (aerial part not specified) Not shown here; see the study · vs untreated / inactive compounds
Eight diterpenes plus viridiflorol, oleanolic acid and alpha-linolenic acid were isolated. 12-O-methyl carnosic acid and alpha-linolenic acid activated PPAR-gamma significantly; the other isolated compounds did not, or only insignificantly.
in-vitro
Methods, limits and funding

Outcomes: Activation of the PPAR-gamma receptor

Funding and conflicts: not applicable

Read: Test-tube result only. Does not show that sage lowers blood sugar in people through this route; authors say the antidiabetic activity 'could in part be mediated' by it.

Cutillas 2017
Composition and Antioxidant, Antienzymatic and Antimicrobial Activities of Volatile Molecules from Spanish Salvia lavandulifolia (Vahl) Essential Oils
Molecules · PMID 28825692 · DOI
Laboratory analysis (GC) and enzyme assays
Salvia lavandulifolia oils from Murcia, Spain Essential oil of Spanish sage
aerial parts (oil) Not shown here; see the study
Main components were camphor, 1,8-cineole, camphene and alpha-pinene (mostly (+)-camphor). All oils inhibited lipoxygenase and acetylcholinesterase; 1,8-cineole was the most active single compound against AChE.
Methods, limits and funding

Outcomes: Composition and in vitro activities

Funding and conflicts: Laboratory study; Spanish sage only.

Read: in-vitro

Czyzewska 2013
Monoterpene α-thujone exerts a differential inhibitory action on GABA(A) receptors implicated in phasic and tonic GABAergic inhibition
Eur J Pharmacol · PMID 23376563 · DOI
Laboratory study (recombinant receptors, cultured neurons)
recombinant GABA-A receptor subtypes; cultured neurons alpha-thujone (pure compound)
alpha-Thujone inhibited all GABA-A receptor types tested by a qualitatively similar mechanism; the strongest effect was on alpha1-beta2-delta receptors, and tonic currents were more sensitive than phasic ones.
Methods, limits and funding

Outcomes: Effect of alpha-thujone on phasic versus tonic GABA-A currents

Funding and conflicts: Isolated cells and recombinant receptors only.

Read: in-vitro

De Leo 1998
[Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent].
Minerva Ginecol · PMID 9677811
Uncontrolled trial
30
Menopausal women with hot flushes
Plant product with sage leaf extract plus alfalfa (Medicago sativa) leaf extract
leaf Not shown here; see the study 3 months
Hot flushes and night sweating disappeared in 20 of 30 women, improved well in 4 and reduced in 6. Basal estradiol, LH, FSH, prolactin and TSH did not change.
20 of 30 women symptom-free (no control group)
Methods, limits and funding

Outcomes: Hot flushes and night sweating; hormone tests in 8 women

Limitations: Mixed product, so sage's own part cannot be separated; no placebo; old (1998) Italian-language paper; only the abstract was available.

Read: abstract

Domaracký 2007
Effects of selected plant essential oils on the growth and development of mouse preimplantation embryos in vivo.
Physiol Res · PMID 16497088 · DOI
Animal research
animal
Female mice Sage essential oil and four other oils in food
essential oil Not shown here; see the study 2 weeks before mating · vs Normal feed
Sage oil changed the distribution of embryos by number of cells in a negative direction; the authors conclude none of the oils helped embryo development.
Methods, limits and funding

Outcomes: Mouse embryo development at day 4

Limitations: Oil in feed; mouse early-embryo study only.

Funding and conflicts: Not stated in abstract

Read: abstract

Doolaege 2011
Absorption, distribution and elimination of carnosic acid, a natural antioxidant from Rosmarinus officinalis, in rats
Plant Foods Hum Nutr · PMID 21751091 · DOI
Animal pharmacokinetic study (rats)
rats (4 intravenous, 9 oral) Carnosic acid (pure)
Not shown here; see the study single dose · vs intravenous versus oral
Bioavailability after 360 min was 40.1%. Traces were found in intestinal content, liver and muscle; 15.6 +/- 8.2% was recovered in feces at 24 h. Present as free (unconjugated) acid; main route of elimination is fecal.
Methods, limits and funding

Outcomes: Absorption, distribution and elimination

Funding and conflicts: Rat study with pure compound from rosemary; not from sage.

Read: animal

EMA Committee on Herbal Medicinal Products (HMPC) 2016
European Union herbal monograph on Salvia officinalis L., folium (sage leaf)
EMA/HMPC/277152/2015 · Source
Authoritative guidance
Adults; traditional use only Sage leaf (tea, extracts, tincture)
leaf
Traditional use only (long-standing use, not proof of effect): mild dyspepsia, excessive sweating, mouth/throat inflammation, minor skin inflammation. Contraindication: hypersensitivity. Use under 18 not recommended (data lacking). Interactions: none reported. Pregnancy and breastfeeding: safety not established, use not recommended. Fertility: no data. Undesirable effects: none known. Overdose: no case from sage leaves; Tea for the stomach and sweating indications: see doctor if no better after 2 weeks (stomach) or 6 weeks (sweating).
Methods, limits and funding

Outcomes: Indications, contraindications, interactions, pregnancy, undesirable effects, overdose

Limitations: Traditional-use document: it does not prove that sage works. Based on long use and on limited data; the herbal-tea doses are not repeated in this file.

Read: full-text

EMA Committee on Herbal Medicinal Products (HMPC) 2016
Public statement on Salvia officinalis L., aetheroleum (sage oil)
EMA/HMPC/41843/2009 Corr. 1 · Source
Authoritative guidance
Sage essential oil as a single-ingredient product Sage essential oil
unspecified
Sage oil is rich in thujone; thujone is toxic and may cause seizures at high doses, shown in animal studies and indicated by case reports. The HMPC concluded the benefit-risk analysis of sage oil is negative and that the data are not adequate for a monograph. Adopted 15 July 2010; corrected text dated 2 February 2016.
Methods, limits and funding

Outcomes: Benefit-risk of sage oil

Limitations: A regulatory judgement about traditional-use medicines, not a ban on culinary sage.

Read: full-text

EMA Committee on Herbal Medicinal Products (HMPC) 2016
Assessment report on Salvia officinalis L., folium and Salvia officinalis L., aetheroleum
EMA/HMPC/150801/2015 · Source
Authoritative guidance
Sage leaf and sage essential oil; regulatory safety review Sage leaf and oil
leaf
Safety sections read in full. No studies on reproductive toxicity; genotoxicity data lacking (so no EU list entry); no suspicion of carcinogenic potential. Human: convulsions reported after prolonged use of alcoholic extracts or the pure oil (German Commission E); intensive-care poisonings (Millet 1981); a poisoning after oil taken for acne (Centini 1987); a toddler (18 months) with seizures after a home-grown sage tea (Tong 2003, as quoted); a newborn and a toddler with seizures after sage oil (Halicioglu 2011). Sage oil is a moderate skin irritant and not recommended in aromatherapy. Patch test: sage gave a positive reaction at 25% in 2 of 55 patients tested for spice allergy (Futrell 1993). Pregnancy and breastfeeding: contraindicated per ESCOP and Barnes; the oil's thujones described as abortifacient and emmenagogic (period-bringing). Interactions: none documented clinically; an in-vitro CYP screen gave no conclusion for sage leaf; a 2009 first version of the monograph carried an interaction warning that was deleted in 2016 because no interactions are documented. EMA notes the lack of adverse reactions suggests thujone may be less neurotoxic than once thought and that its danger may be overestimated because of problems with liquor misuse.
Methods, limits and funding

Outcomes: See the study for details.

Limitations: Several statements are quotes of older books (ESCOP, Barnes, Wichtl, Commission E) and of case reports we could not open ourselves (Millet, Centini, Tong). Treat those as reported by EMA.

Read: full-text (safety sections)

German Commission E (as cited in EMA/HMPC/150801/2015) 1990
German Commission E monograph on sage leaf (Salviae folium), as quoted by EMA
Commission E (cited in EMA assessment report) · Source
Authoritative guidance
Adults Sage leaf, extracts and oil
leaf
As cited by EMA: epileptiform convulsions can occur after prolonged use of alcoholic extracts or of the pure essential oil; the pure oil and alcoholic extracts should not be taken in pregnancy.
Methods, limits and funding

Outcomes: Safety statements

Limitations: We did not open the Commission E monograph itself; this is only what the EMA report says it states.

Read: summary-only (quoted by EMA)

Ghorbani 2017
Pharmacological properties of Salvia officinalis and its components
J Tradit Complement Med · PMID 29034191 · DOI
Narrative review
not applicable (review of preclinical and clinical work) Salvia officinalis and its components
leaf/aerial parts (not specified in abstract)
Lists anticancer, anti-inflammatory, antinociceptive, antioxidant, antimicrobial, antimutagenic, antidementia, hypoglycemic and hypolipidemic findings; notes folk uses for seizure, ulcers, gout, rheumatism, inflammation, dizziness, tremor, paralysis, diarrhea and high blood sugar.
Methods, limits and funding

Outcomes: Overview of reported pharmacology

Funding and conflicts: Narrative review, no stated method for selecting studies in the abstract; most listed effects come from cell and animal work.

Read: mixed

Halicioglu 2011
Toxicity of Salvia officinalis in a newborn and a child: an alarming report.
Pediatr Neurol · PMID 21907890 · DOI
Case series
2
A 33-day-old boy given sage oil for colic and a 5-year-old girl who took about 5 ml of sage oil for stomach colic (case descriptions from the EMA report; the abstract describes a newborn and a toddler)
Sage essential oil (accidental or home use)
unspecified Not shown here; see the study
Two children had generalised tonic-clonic seizures after sage oil; no other cause was found in either. One seizure was a single event, the other repeated in the newborn. Both had good outcomes. The authors say a first unexplained seizure should prompt asking about herbal products.
Methods, limits and funding

Outcomes: Seizures after exposure to sage oil

Limitations: Two cases only; the exact oil, amount and thujone content were not measured. Age details differ between the abstract (newborn and toddler) and the EMA summary (33-day-old and 5-year-old).

Funding and conflicts: Not stated

Read: abstract

Hellum 2007
The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.
Basic Clin Pharmacol Toxicol · PMID 17214607 · DOI
Laboratory research
in-vitro
Cultured human liver cells Common sage commercial product extract
leaf Not shown here; see the study
Common sage showed a general inhibitory potential on these enzymes in cells; St John's wort, valerian and ginkgo were singled out as the likelier real-world interactors.
Methods, limits and funding

Outcomes: CYP1A2, 2D6, 3A4 activity

Limitations: Cell study.

Funding and conflicts: Not stated in abstract

Read: abstract

Hellum 2009
Trade herbal products and induction of CYP2C19 and CYP2E1 in cultured human hepatocytes.
Basic Clin Pharmacol Toxicol · PMID 19371257 · DOI
Laboratory research
in-vitro
Cultured human liver cells Common sage commercial product extract
leaf Not shown here; see the study 72 hours · vs Rifampicin as control
Common sage raised CYP2C19 activity in a dose-dependent way; the authors say sage should be considered a possible candidate for interaction with some CYP2C19 drugs.
Methods, limits and funding

Outcomes: CYP2C19 and CYP2E1 activity

Limitations: Cell study; clinical relevance unknown.

Funding and conflicts: Not stated in abstract

Read: abstract

Hubbert 2006
Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis.
Eur J Med Res · PMID 16504956
Controlled trial
286
Adults with acute viral sore throat (pharyngitis), two study parts (122 and 164)
Sage spray (Salvia officinalis fluid extract), 15% spray
unspecified (fluid extract) Not shown here; see the study 3 days · vs Placebo spray
The 15% spray beat placebo for the throat pain score over 2 hours (statistically significant). The 30% and 5% sprays looked unlikely to beat placebo at the interim check. Only minor side effects: dry throat or mild burning.
Statistically significant pain relief vs placebo in the first 2 hours; the abstract gives no numbers
Methods, limits and funding

Outcomes: Throat pain intensity on a 100 mm scale over the first 2 hours after the first dose

Limitations: Abstract gives no pain scores or confidence intervals; relief was measured over the first 2 hours only; adaptive design with an interim look; one company-linked trial.

Funding and conflicts: Lead author at Sidroga GmbH, the company; funding not stated in the abstract.

Read: abstract

Höld 2000
Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification
Proc Natl Acad Sci U S A · PMID 10725394 · DOI
Animal and laboratory study (mice, fly, rat neurons, mouse brain membranes)
mice; Drosophila; rat dorsal root ganglion neurons; mouse brain membranes alpha-thujone (pure compound)
Not shown here; see the study · vs untreated / diazepam and phenobarbital as rescue
Four lines of evidence show alpha-thujone is a modulator of the GABA type A receptor (it suppressed GABA-induced currents in rat neurons, fully reversible after washout). In mouse liver microsomes it is rapidly converted (mainly to 7-hydroxy-alpha-thujone) by cytochrome P450, and the metabolites were less toxic. Diazepam and phenobarbital relieved the poisoning signs in mice.
Methods, limits and funding

Outcomes: Mechanism of alpha-thujone neurotoxicity and its metabolism

Funding and conflicts: Animal and cell work; doses that cause convulsions in animals are not translated into human doses here.

Read: animal

Höld 2001
Detoxification of alpha- and beta-Thujones (the active ingredients of absinthe): site specificity and species differences in cytochrome P450 oxidation in vitro and in vivo
Chem Res Toxicol · PMID 11368559 · DOI
Animal and laboratory study (liver microsomes, mice, rats, flies)
mouse, rat and human liver microsomes; human recombinant CYP3A4; orally treated mice and rats; Drosophila alpha-thujone and beta-thujone (pure compounds)
Not shown here; see the study
Hydroxylation by P450 enzymes (including human CYP3A4) is a detoxification step: P450 inhibitors synergised thujone toxicity in flies, and six metabolites were weaker than thujone at the GABA-A receptor site and as toxicants. Metabolic sites differ between species.
Methods, limits and funding

Outcomes: Thujone metabolism by cytochrome P450 and toxicity of the metabolites

Funding and conflicts: Mostly animal and microsome data; species differences are large.

Read: animal

Jinhua 2019
Ursolic acid: Pharmacokinetics process in vitro and in vivo, a mini review
Arch Pharm (Weinheim) · PMID 30663087 · DOI
Mini review
not applicable Ursolic acid
Oral bioavailability is low because it is absorbed mainly by passive diffusion; few pharmacokinetic studies exist and new formulations are being tested to improve it.
Methods, limits and funding

Outcomes: Pharmacokinetics of ursolic acid

Funding and conflicts: Short review; no data specific to sage.

Read: mixed

Kavvadias 2003
Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor.
Planta Med · PMID 12624814 · DOI
Laboratory research
in-vitro
Human brain receptor binding assay Sage leaf methanol extract components
leaf Not shown here; see the study
Apigenin, hispidulin, cirsimaritin and two diterpenes (7-methoxyrosmanol, galdosol) bound the benzodiazepine receptor in a test tube.
Methods, limits and funding

Outcomes: Benzodiazepine-receptor binding

Limitations: Test-tube only.

Funding and conflicts: Not stated in abstract

Read: abstract

Kennedy 2006
Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery.
Neuropsychopharmacology · PMID 16205785 · DOI
Controlled trial
30
Healthy young adults
Dried sage leaf (Salvia officinalis), capsules
leaf Not shown here; see the study Single doses 7 days apart; mood checked before and at 1 and 4 hours · vs Placebo (crossover)
Both doses improved mood before the stress task. The lower-dose anxiety benefit disappeared after doing the stress task. A lab test on a sage leaf extract also blocked cholinesterase enzymes.
Numbers not in the abstract.
Methods, limits and funding

Outcomes: Bond-Lader mood scales and State Trait Anxiety Inventory before and after a 20-minute stress task (DISS multitasking battery); task performance

Limitations: Single doses in young healthy people; effect on anxiety did not hold during the stress task; opposite effects on task performance at the two doses. Not a test in people with an anxiety disorder.

Read: abstract

Kennedy 2011
Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults.
J Psychopharmacol · PMID 20937617 · DOI
Controlled trial
36
Healthy adults
Essential oil of Salvia lavandulaefolia (almost all monoterpenoids), capsules
unspecified (essential oil) Not shown here; see the study Single dose; tests at 1 and 4 hours · vs Placebo (crossover, 7 days apart)
Better secondary memory and attention tasks, most at 1 hour; less mental fatigue and more alertness, most at 4 hours. In the lab the oil strongly blocked human acetylcholinesterase.
Numbers not in the abstract.
Methods, limits and funding

Outcomes: Computerised memory and attention tasks, Cognitive Demand Battery, mood

Limitations: Single dose, short follow-up, healthy adults.

Read: abstract

Kianbakht 2011
Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial.
Phytother Res · PMID 21506190 · DOI
Controlled trial
67
Adults with high cholesterol and/or triglycerides, Karaj, Iran (34 sage, 33 placebo)
Sage (Salvia officinalis) leaf extract capsules
leaf Not shown here; see the study 2 months · vs Placebo
Total cholesterol (p<0.001), triglyceride (p=0.001), LDL (p=0.004) and VLDL (p=0.001) were lower and HDL higher (p<0.001) than placebo. No effect on liver enzymes or creatinine; no adverse effects reported.
Lower total cholesterol, triglyceride, LDL, VLDL and higher HDL vs placebo (no sizes in abstract)
Methods, limits and funding

Outcomes: Total cholesterol, triglyceride, LDL, VLDL, HDL, liver enzymes, creatinine

Limitations: Small; abstract gives p-values but no sizes; one research group; 2 months; not replicated outside Iran.

Read: abstract

Kianbakht 2013
Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial.
Complement Ther Med · PMID 24050577 · DOI
Controlled trial
80
Adults with type 2 diabetes and high blood fats, Karaj, Iran (40 sage, 40 placebo)
Sage (Salvia officinalis) leaf extract capsules
leaf Not shown here; see the study 3 months · vs Placebo
Fasting glucose, HbA1c, total cholesterol, triglyceride and LDL were lower and HDL higher with sage than placebo (P between <0.001 and 0.01). Percent differences reported as 32.2% (glucose), 22.7% (HbA1c), 16.9% (total cholesterol), 56.4% (triglyceride), 35.6% (LDL), 27.6% (HDL). No effect on liver enzymes or creatinine. No adverse effects reported.
Glucose 32.2%, HbA1c 22.7%, total cholesterol 16.9%, triglyceride 56.4%, LDL 35.6%, HDL 27.6% (percent difference vs placebo, as reported) (Glucose 26.5-37.9; HbA1c 16.8-28.6; total cholesterol 9.7-24.1; triglyceride 36.1-76.7; LDL 29.9-41.3; HDL 15.8-39.4 (percent difference))
Methods, limits and funding

Outcomes: Fasting glucose, HbA1c, total cholesterol, triglyceride, LDL, HDL, liver enzymes, creatinine

Limitations: Very large effects from one small trial by one research group; the abstract does not give raw values; same group ran the two other lipid trials; not replicated outside Iran; 3 months.

Read: abstract

Kianbakht 2016
Salvia officinalis (Sage) Leaf Extract as Add-on to Statin Therapy in Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Clinical Trial.
Int J Mol Cell Med · PMID 27942500
Controlled trial
100
Adults with type 2 diabetes and high cholesterol already on glyburide, metformin and atorvastatin, Karaj, Iran (50 each group)
Sage (Salvia officinalis) leaf extract capsules, as an add-on to usual drugs
leaf Not shown here; see the study 2 months · vs Placebo
Fasting glucose, 2-hour glucose, HbA1c, total cholesterol, LDL and triglyceride were lower and HDL higher than with placebo (P<0.05). No effect on other measures; no adverse effect reported.
Lower glucose, HbA1c and LDL, higher HDL than placebo (P<0.05); no numbers in the abstract
Methods, limits and funding

Outcomes: Fasting glucose, after-meal glucose, HbA1c, cholesterol, LDL, triglyceride, HDL, liver enzymes, creatinine, BMI

Limitations: Same research group as the 2011 and 2013 trials; abstract gives no numbers; short; patients were already on several drugs, so any combined effect on blood sugar needs a doctor's attention.

Read: abstract

Krol 2022
White Sage (Salvia apiana)-a Ritual and Medicinal Plant of the Chaparral: Plant Characteristics in Comparison with Other Salvia Species
Planta Med · PMID 33890254 · DOI
Narrative review
not applicable Salvia apiana (white sage)
leaf
White sage is an evergreen subshrub of California and Baja California chaparral, used by the Chumash as a calmative, diuretic and cold remedy; it carries substantial essential oil plus triterpenes, diterpenes and flavonoids.
Methods, limits and funding

Outcomes: Botany, chemistry and use of white sage

Funding and conflicts: Review.

Read: mixed

Lachenmeier 2010
Risk assessment of thujone in foods and medicines containing sage and wormwood--evidence for a need of regulatory changes?
Regul Toxicol Pharmacol · PMID 20727933 · DOI
Other
animal
Risk assessment of published animal data, including a long-term US National Toxicology Program study Thujone from sage and wormwood
unspecified Not shown here; see the study
they view short-term medicinal use of these herbs as safe and say the evidence does not call for regulatory change.
Methods, limits and funding

Outcomes: See the study for details.

Limitations: Animal data only, converted to human estimates; authors also used tea thujone levels that vary a lot between products. Not a human trial.

Funding and conflicts: Not stated in abstract

Read: abstract

Li 2018
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics
Acta Pharmacol Sin · PMID 29698387 · DOI
Narrative review
not applicable Salvia miltiorrhiza (Danshen) and its components
root (the traditional drug; not stated in the abstract I read, so not verified here)
Lipophilic tanshinones and water-soluble phenolic acids (danshensu, salvianolic acids A and B) are said to underlie its cardiovascular and cerebrovascular actions.
Methods, limits and funding

Outcomes: Cardiovascular actions of Danshen

Funding and conflicts: Review of mostly preclinical work. Danshen is a different plant from garden sage.

Read: mixed

Lile 2026
Comparative Clinical Evaluation of Chamomile, Sage, and Ginger Mouthwashes in Reducing Plaque and Gingival Inflammation.
Antibiotics (Basel) · PMID 42192655 · DOI
Controlled trial
175
Healthy young adults, 5 groups of 35 (chamomile, sage, ginger, placebo, chlorhexidine), Romania
Sage (Salvia officinalis) 2% aqueous infusion used as a mouthwash
unspecified Not shown here; see the study 12 weeks · vs Placebo rinse; chlorhexidine as a standard comparison
Plaque and gum-inflammation scores fell over time in all active rinses, and all active rinses did better than placebo; the three herbal rinses did not differ from each other.
All herbal rinses better than placebo; no between-herb difference (effect sizes for sage alone not in the abstract)
Methods, limits and funding

Outcomes: Plaque index (Silness-Loe) and gingival index (modified Loe-Silness)

Limitations: Healthy young adults, not people with gum disease; no sage-only numbers in the abstract; published 2026 and not yet checked by others; the authors themselves say mechanism claims are not possible.

Funding and conflicts: No conflicts declared.

Read: abstract

Lima 2007
Drinking of Salvia officinalis tea increases CCl(4)-induced hepatotoxicity in mice.
Food Chem Toxicol · PMID 17084954 · DOI
Animal research
animal
Mice of both sexes Sage tea (infusion) as drinking fluid
leaf Not shown here; see the study 14 days before carbon tetrachloride · vs Water
Sage tea alone had no toxic effect but increased carbon-tetrachloride liver injury (higher transaminases, more tissue damage) and raised CYP2E1; the authors warn herb-drug interactions with drugs cleared by phase I enzymes are possible. Effect was higher in females.
Methods, limits and funding

Outcomes: Liver injury after carbon tetrachloride

Limitations: Mouse model with a liver poison; unknown relevance to people.

Funding and conflicts: Not stated in abstract

Read: abstract

Maggini 2023
The Different Phytochemical Profiles of Salvia officinalis Dietary Supplements Labelled for Menopause Symptoms.
Molecules · PMID 38202677 · DOI
Other
4
Four commercial sage supplements sold for menopause
Sage supplements
leaf Not shown here; see the study
None of the four extracts contained thujones or isoflavones; polyphenol content differed by up to 1.8 to 3.2 times between products.
Methods, limits and funding

Outcomes: Thujone and phenolic content

Limitations: Only four products tested.

Funding and conflicts: No conflict declared

Read: abstract

Miroddi 2014
Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease.
CNS Neurosci Ther · PMID 24836739 · DOI
Systematic review
Eight acute-effect studies in healthy people (six on cognitive performance) and two Alzheimer's trials, plus toxicity reports S. officinalis and S. lavandulaefolia (extracts, essential oil, raw material)
unspecified Not shown here; see the study Various · vs Various
The authors found beneficial effects on cognitive performance in healthy people and in people with dementia or cognitive impairment and called it safe for this use, but said the promising results are weakened by method problems, very different preparations and poor product detail. They call for better trials.
No pooled numbers in the abstract.
Methods, limits and funding

Outcomes: Memory, cognition, Alzheimer's disease, safety

Limitations: Abstract only. No formal GRADE rating. The review mixes different species and forms.

Read: abstract

Mirza 2023
Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action
Molecules · PMID 36903551 · DOI
Narrative review
not applicable Carnosic acid
Review stating that carnosic acid is abundant in Rosmarinus and Salvia and summarising mechanisms behind its neuroprotective role in lab and animal models. The abstract gives no figures.
Methods, limits and funding

Outcomes: Neuroprotective mechanisms of carnosic acid

Funding and conflicts: Abstract only; no human data.

Read: mixed

Monsen 2021
A mouth rinse based on a tea solution of Salvia officinalis for oral discomfort in palliative cancer care: a randomized controlled trial.
Support Care Cancer · PMID 33586003 · DOI
Controlled trial
88
Adults with advanced cancer in a hospice unit, Norway (73 completed)
Sage (Salvia officinalis) tea-based mouth rinse
leaf (tea) Not shown here; see the study 4 days · vs Normal saline rinse
Overall oral health improved equally with sage and saline (p<0.001 in both). Dry mouth ratings improved more with sage (p=0.036 and p=0.045). Plaque on teeth improved in both groups. The authors report no significant overall difference between sage and saline.
No overall difference vs saline; dry mouth slightly better with sage (p=0.036 and 0.045)
Methods, limits and funding

Outcomes: Patient-reported oral symptoms (EORTC QLQ-OH17, 0-10 scales) and oral examination

Limitations: Only dry mouth favoured sage, among many outcomes tested; very ill patients; 17% dropped out; saline is itself helpful.

Funding and conflicts: No competing interests declared.

Registration: NCT02067572

Read: abstract

Moradi 2023
The Effect of Salvia Officinalis on Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis.
Int J Community Based Nurs Midwifery · PMID 37489230 · DOI
Systematic review
310
Postmenopausal women; 4 trials (310 people) in the meta-analysis
Salvia officinalis (various preparations)
unspecified Not shown here; see the study Varied · vs Placebo
All 4 trials reported fewer or milder hot flashes with sage. Pooled effect on frequency ES -1.12 (95% CI -2.37 to 0.14; I2 71%). Pooled effect on severity ES -2.05 (95% CI -6.53 to 2.43; I2 70%), not significant.
Frequency ES -1.12; severity ES -2.05 (both with wide intervals) (Frequency -2.37 to 0.14; severity -6.53 to 2.43)
Methods, limits and funding

Outcomes: Hot flash frequency, severity, duration

Limitations: Only 4 small trials; high variation between trials (I2 about 70%); the frequency interval reaches 0.14, so it just crosses zero even though the abstract calls it significant; no GRADE rating in the abstract.

Funding and conflicts: None declared.

Read: abstract

Mutluay Yayla 2016
Sage tea-thyme-peppermint hydrosol oral rinse reduces chemotherapy-induced oral mucositis: A randomized controlled pilot study.
Complement Ther Med · PMID 27515877 · DOI
Controlled trial
60
Adults on 5-fluorouracil chemotherapy, Ankara, Turkey
Sage tea-thyme-peppermint hydrosol oral rinse (a three-plant mix)
unspecified Not shown here; see the study Assessed on day 5 and day 14 · vs Basic oral care only (no placebo rinse)
Grade 1 mucositis on day 5: 10% with the rinse versus 53.3% with basic care. By day 14 most patients in both groups had no mucositis.
Grade 1 mucositis at day 5: 10% vs 53.3%
Methods, limits and funding

Outcomes: Oral mucositis grade (WHO scale)

Limitations: Open-label, no placebo rinse; mixture of three herbs, so sage cannot be separated; pilot study; the abstract gives no p-value.

Read: abstract

National Institute of Child Health and Human Development (NIH) 2025
Sage. Drugs and Lactation Database (LactMed)
LactMed (NCBI Bookshelf) · PMID 30000875
Authoritative guidance
Breastfeeding mothers and infants (no studies located) Sage (Salvia officinalis)
leaf Not shown here; see the study
LactMed states that sage and Salvia fruticosa purportedly reduce lactation and have been used to help with weaning or an overabundant milk supply, but no scientific studies could be located on sage's effect on milk supply and no data exist on its safety in nursing mothers or infants. Thujone and camphor are neurotoxic in high doses.
No study; claim rests on traditional use
Methods, limits and funding

Outcomes: Effect on milk supply; safety in nursing

Limitations: A database entry summarizing the absence of studies, not a trial.

Read: abstract

Orhan 2008
Activity of essential oils and individual components against acetyl- and butyrylcholinesterase
Z Naturforsch C J Biosci · PMID 18810999 · DOI
Laboratory study (enzyme assay)
in vitro AChE and BChE assays of 19 essential oils and many single compounds Essential oils of dill, fennel, lemon balm, mints, lavender, basil, oreganos, clary sage (S. sclarea), common sage (S. officinalis) and savory; single terpenes
aerial parts (oils) Not shown here; see the study
Almost all oils inhibited both enzymes by more than 80% at 1 mg/ml, while single components were less active than the oils. The abstract does not give a separate figure for the S. officinalis oil.
Methods, limits and funding

Outcomes: Inhibition of AChE and BChE

Funding and conflicts: Very high concentration; one S. officinalis oil sample only; screening study.

Read: in-vitro

Pelkonen 2013
Thujone and thujone-containing herbal medicinal and botanical products: toxicological assessment
Regul Toxicol Pharmacol · PMID 23201408 · DOI
Narrative toxicological review
not applicable Thujone and thujone-containing herbal products
Neurotoxicity is the principal toxic outcome. In animals thujone inhibits the GABA-A receptor and causes excitation and convulsions in a dose-dependent way. In human liver preparations CYP2A6 is the main metabolising enzyme, then CYP3A4 and, to a lesser extent, CYP2B6. Equivocal evidence of carcinogenicity in rats. Key gaps: human dose-concentration-effect relationships and bioavailability.
Methods, limits and funding

Outcomes: Toxicological assessment of thujone

Funding and conflicts: Review of animal and in vitro data; the author notes uncertainty about the doses that matter in humans.

Read: mixed

Perry 2002
Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo.
Phytomedicine · PMID 11926204 · DOI
Animal research
animal
Rats Essential oil of Salvia lavandulaefolia, by mouth
unspecified (essential oil) Not shown here; see the study 5 days · vs Untreated
Cholinesterase activity fell in the striatum at both doses and in the hippocampus at the higher dose, but not significantly in the cortex.
Not given in the abstract.
Methods, limits and funding

Outcomes: Brain cholinesterase activity after death

Limitations: Rat study. The abstract says this may help explain the traditional use for memory but it is not human evidence.

Read: abstract

Pitarokili 2002
Composition and antifungal activity on soil-borne pathogens of the essential oil of Salvia sclarea from Greece
J Agric Food Chem · PMID 12405762 · DOI
Laboratory analysis (GC MS)
wild Salvia sclarea (clary sage) from two Greek localities Essential oil
aerial parts Not shown here; see the study
Linalyl acetate (19.75-31.05%) and linalool (18.46-30.43%) were the major components. (The abstract is cut off after that.)
Methods, limits and funding

Outcomes: Oil composition

Funding and conflicts: Greek wild plants only.

Read: in-vitro

Raal 2007
Composition of the essential oil of Salvia officinalis L. from various European countries.
Nat Prod Res · PMID 17487611 · DOI
Other
Sage leaves from several European countries Sage leaf essential oil
leaf Not shown here; see the study
Main components were 1,8-cineole, camphor, alpha-thujone, beta-thujone, borneol and viridiflorol; sage cultivated in Estonia had comparatively high thujones; three samples had less oil than the pharmacopoeia standard (10 mL/kg).
Methods, limits and funding

Outcomes: Oil composition

Limitations: Chemistry only.

Funding and conflicts: Not stated in abstract

Read: abstract

Radulović 2017
Toxic essential oils. Part V: Behaviour modulating and toxic properties of thujones and thujone-containing essential oils of Salvia officinalis L., Artemisia absinthium L., Thuja occidentalis L. and Tanacetum vulgare L.
Food Chem Toxicol · PMID 28472675 · DOI
Other
animal
Four plant essential oils (sage, wormwood, thuja, tansy) tested in rats and brine shrimp, with chemical analysis Essential oils containing thujones
leaf Not shown here; see the study
Statistics suggested the toxic and behaviour-changing effects of these oils are not caused by thujones alone; other oil components also correlated with toxicity and brain effects.
Methods, limits and funding

Outcomes: Behaviour and toxicity compared with oil composition

Limitations: Animal and lab study; small number of oils.

Funding and conflicts: Not stated in abstract

Read: abstract

Rahte 2013
Salvia officinalis for hot flushes: towards determination of mechanism of activity and active principles.
Planta Med · PMID 23670626 · DOI
Laboratory research
in-vitro
Cell assays Sage tincture and fractions
leaf Not shown here; see the study
The whole tincture showed no estrogenic effect; a water-ethanol sub-extract did (EC50 64 micrograms/mL), traced to luteolin glucuronide or glucoside. The authors suggest common plant flavonoids contribute to the hot-flush effect.
Methods, limits and funding

Outcomes: Estrogen-like and serotonin-uptake activity

Limitations: Cell test; does not show an effect in women.

Funding and conflicts: Not stated in abstract

Read: abstract

Rau 2006
Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma
Planta Med · PMID 16858665 · DOI
Laboratory study (cell reporter assay)
Cos7 cells carrying a Gal4-PPAR-gamma fusion receptor and luciferase reporter 80% aqueous ethanol extracts of sage and rosemary; carnosic acid; carnosol
leaf · vs untreated cells
Sage extract activated the receptor with an EC50 of 33.7 +/- 7.3 mg/L (rosemary 22.8 +/- 8.4 mg/L). Carnosic acid EC50 19.6 +/- 2.0 microM; carnosol EC50 41.2 +/- 5.9 microM.
Methods, limits and funding

Outcomes: Activation of human PPAR-gamma

Funding and conflicts: Reporter-cell assay; no animal or human data in this paper; the 'glucose-lowering effect' it mentions was reported for rosemary.

Read: in-vitro

Rivera 2014
Central α- and β-thujone: similar anxiogenic-like effects and differential modulation on GABAA receptors in neonatal chicks.
Brain Res · PMID 24486357 · DOI
Animal research
animal
3-day-old chicks given thujone directly into the brain Alpha- and beta-thujone
pure compound Not shown here; see the study Single · vs Control
Higher doses caused convulsions. Both thujones reduced movement in an open-field test at 78 nmol. Alpha-thujone suppressed a stress-induced change in a benzodiazepine-sensitive GABA-A receptor measure. The paper says the convulsant action of alpha-thujone is attributed to blocking GABA-A receptors.
Methods, limits and funding

Outcomes: Anxiety-like behaviour and GABA-A receptor changes

Limitations: Chick brain injection model; not relevant to dose by mouth in people.

Funding and conflicts: Not stated in abstract

Read: abstract

Romo Vaquero 2013
Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats
Mol Nutr Food Res · PMID 23625681 · DOI
Animal pharmacokinetic study (Zucker rats)
lean and obese Zucker rats Rosemary extract rich in carnosic acid
leaf Not shown here; see the study
26 compounds tentatively identified. Main metabolites were glucuronides of carnosic acid, carnosol and rosmanol; small amounts of carnosic acid and trace metabolites reached the brain. All metabolites were detected as early as 25 min after the dose.
Methods, limits and funding

Outcomes: Metabolites in intestine, liver, plasma, brain

Funding and conflicts: Rosemary extract in rats; sage contains the same diterpenes but this was not tested here.

Read: animal

Sabry 2022
Estrogenic activity of Sage (Salvia officinalis L.) aerial parts and its isolated ferulic acid in immature ovariectomized female rats.
J Ethnopharmacol · PMID 34499963 · DOI
Animal research
animal
Young rats with ovaries removed Sage aerial-part ethanol extract and ferulic acid
aerial parts Not shown here; see the study 7 days · vs Untreated ovariectomised rats
Uterine weight rose and LH/FSH fell, consistent with an estrogen-like effect.
Methods, limits and funding

Outcomes: Uterus weight, hormones, tissue changes

Limitations: Rat study at doses given per kg; unknown how it applies to people.

Funding and conflicts: Not stated in abstract

Read: abstract

Savelev 2003
Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil.
Pharmacol Biochem Behav · PMID 12895684 · DOI
Laboratory research
in-vitro
Lab test of eight terpenes found in Spanish sage oil Individual terpenes from Salvia lavandulaefolia essential oil
unspecified (essential oil constituents) Not shown here; see the study Lab experiment
1,8-cineole was the strongest single compound (IC50 0.06 mg/mL, close to that of the whole oil at 0.05 mg/mL). Some combinations boosted each other and some worked against each other.
IC50: 1,8-cineole 0.06 +/- 0.01 mg/mL; whole oil 0.05 +/- 0.01 mg/mL.
Methods, limits and funding

Outcomes: Acetylcholinesterase inhibition

Limitations: Test-tube work only.

Read: abstract

Schapowal 2009
Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial.
Eur J Med Res · PMID 19748859 · DOI
Controlled trial
154
Adults with acute sore throat in Swiss practices
Echinacea/sage throat spray
leaf Not shown here; see the study Up to 5 days · vs Chlorhexidine/lidocaine spray
Response was 63.8% with echinacea/sage and 57.8% with the comparison spray; both were very well tolerated.
Methods, limits and funding

Outcomes: Symptom response over 3 days

Limitations: Combination product; no placebo group.

Funding and conflicts: Not stated in abstract

Read: abstract

Scholey 2008
An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers.
Psychopharmacology (Berl) · PMID 18350281 · DOI
Controlled trial
20
Healthy older adults, over 65 (average age about 73)
Standardised extract of Salvia officinalis
unspecified Not shown here; see the study Five visits 7 days apart; tests up to 6 hours · vs Placebo (five-period crossover)
Other doses helped secondary memory to a lesser extent.
Numbers not in the abstract.
Methods, limits and funding

Outcomes: Cognitive Drug Research battery

Limitations: Only 20 volunteers and single doses. The authors call for larger studies with different dosing. Extract type is described only as standardised.

Read: abstract

Sá 2009
Sage tea drinking improves lipid profile and antioxidant defences in humans
Int J Mol Sci · PMID 19865527 · DOI
Non randomized pilot crossover
6
healthy women
Sage tea
leaf Not shown here; see the study 4 weeks, with follow-up two weeks after · vs before-and-after (crossover)
No effect on plasma glucose. Lower LDL and total cholesterol and higher HDL during and two weeks after the tea; higher Hsp70 in lymphocytes and higher erythrocyte SOD and CAT activity. No liver or other adverse effects were seen.
Methods, limits and funding

Outcomes: Glucose, lipids, transaminases, antioxidant enzymes

Funding and conflicts: Only six women, no randomisation, no placebo.

Read: human

Thamm 2018
Quantification of α-Thujone and Its Metabolites in Human Urine after Consumption of a Sage Infusion Using Stable Isotope Dilution Assays.
Toxins (Basel) · PMID 30513900 · DOI
Other
Healthy volunteers who drank sage tea (number not given in the abstract) Sage infusion (tea)
leaf Not shown here; see the study Single exposure
After tea, breakdown products 4-hydroxythujone and 7-hydroxythujone were found in urine; alpha-thujone itself was found only in very low amounts (highest 94 ng/L in the volunteer with the highest dose of 14.3 micrograms per kg body weight). 2-hydroxythujone was not detected.
Methods, limits and funding

Outcomes: Alpha-thujone and its breakdown products in urine

Limitations: Lab method study with a small number of volunteers; no symptoms or blood levels are reported in the abstract.

Funding and conflicts: No conflict declared

Read: abstract

Tober 2019
Modulation of neurological pathways by Salvia officinalis and its dependence on manufacturing process and plant parts used.
BMC Complement Altern Med · PMID 31196061 · DOI
Laboratory research
in-vitro
Cell and tissue receptor assays, including hypothalamic tissue from two women Thujone-free hydroalcoholic extract of fresh sage leaf
leaf Not shown here; see the study
The extract bound GABA-A (IC50 89 micrograms/mL) and GABA-B receptors (229), and strongly bound adrenaline alpha-2A, mu-opioid, muscarinic M3 and serotonin 5-HT1A receptors; fresh leaf was 2 to 4 times more active than dried.
Methods, limits and funding

Outcomes: Binding to brain receptors

Limitations: Test-tube binding; does not show a sedative effect in people.

Funding and conflicts: Not stated in abstract

Read: abstract

Tundis 2020
Salvia officinalis L. from Italy: A Comparative Chemical and Biological Study of Its Essential Oil in the Mediterranean Context
Molecules · PMID 33321838 · DOI
Laboratory analysis (GC MS) and enzyme assays
sage oils from three areas of southern Italy Essential oil
aerial parts (oil) Not shown here; see the study
Most abundant: camphor 16.16-18.92%, 1,8-cineole 8.80-9.86%, beta-pinene 3.08-9.14%, camphene 6.27-8.08%, alpha-thujone 1.17-9.26%. The best BChE inhibition came from one sample (IC50 33.13 microg/mL).
Methods, limits and funding

Outcomes: Composition, AChE/BChE inhibition, antioxidant tests

Funding and conflicts: Three samples from one region; amounts vary with environment.

Read: in-vitro

US Food and Drug Administration (via eCFR) 2025
Code of Federal Regulations Title 21, section 182.10: spices and other natural seasonings and flavorings
21 CFR 182.10 · Source
Authoritative guidance
Food use Culinary sage
leaf
Sage (Salvia officinalis L.) is listed among the spices and natural seasonings that are generally recognized as safe (GRAS) when used as food flavouring.
Methods, limits and funding

Outcomes: US food status of sage

Limitations: Covers culinary use only. It says nothing about medicinal amounts, tinctures, supplements or the essential oil as a medicine, and FDA does not approve herbal supplements for safety or effect.

Read: summary-only

Usano-Alemany 2014
Chemical description and essential oil yield variability of different accessions of Salvia lavandulifolia
Nat Prod Commun · PMID 24689309
Field and laboratory analysis
Spanish sage (S. lavandulifolia) accessions grown wild and in a plot Essential oil
aerial parts Not shown here; see the study a whole growth cycle
Oil yield peaked at full seed maturation (average 1.74%). Main compounds: alpha-pinene, beta-pinene plus myrcene, limonene, 1,8-cineole, camphor and beta-caryophyllene.
Methods, limits and funding

Outcomes: Oil yield and composition

Funding and conflicts: Spanish sage, not common sage.

Read: in-vitro

Wake 2000
CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory
J Ethnopharmacol · PMID 10687867 · DOI
Laboratory study (human brain membranes)
homogenates of human cerebral cortex membranes Ethanolic extracts of European medicinal plants
aerial parts
The most potent extracts, from one lemon balm accession, three Salvia species and wormwood, had IC50 values below 1 mg/ml. Differences between accessions of one species were considerable. The abstract does not say which three Salvia species.
Methods, limits and funding

Outcomes: Displacement of nicotinic and muscarinic ligands

Funding and conflicts: Binding assay in post-mortem tissue; does not prove action in a living brain.

Read: in-vitro

Walch 2011
Determination of the biologically active flavour substances thujone and camphor in foods and medicines containing sage (Salvia officinalis L.).
Chem Cent J · PMID 21777420 · DOI
Other
Commercial sage foods and medicines (teas, tinctures) Sage tea infusions
leaf Not shown here; see the study
Brewing raised thujone and camphor for about 5 minutes, then levelled off. About 30% of the thujone in an ethanol extract is recovered in tea. Average thujone and camphor were 4.4 and 16.7 mg per litre in food teas and 11.3 and 25.4 mg per litre in medicinal teas.
Methods, limits and funding

Outcomes: Thujone and camphor in sage products

Limitations: Laboratory survey;

Funding and conflicts: Not stated in abstract

Read: abstract

Walch 2012
Holistic Control of Herbal Teas and Tinctures Based on Sage (Salvia officinalis L.) for Compounds with Beneficial and Adverse Effects using NMR Spectroscopy.
Anal Chem Insights · PMID 22493561 · DOI
Other
108
108 sage products (teas and tinctures) tested by NMR
Sage teas and tinctures
leaf Not shown here; see the study
Total thujone in tea infusions ranged from not detectable to 37.5 mg per litre (average 9.2 mg/L); tinctures ranged from not detectable to 409 mg per litre (average 107 mg/L). Camphor in infusions 2.1 to 43.7 mg/L (average 14.1) and in tinctures up to 748 mg/L (average 206).
Methods, limits and funding

Outcomes: Thujone and camphor in sage products

Limitations: Product survey in one lab; products tested at one time point; which brands are not named in the abstract.

Funding and conflicts: Not stated in abstract

Read: abstract

Weishaupt 2023
Reduction of Viral Load in Patients with Acute Sore Throats: Results from an Observational Clinical Trial with Echinacea/Salvia Lozenges.
Complement Med Res · PMID 36889292 · DOI
Observational
74
People aged 13-69 with a sore throat of less than 48 hours; 18 had a virus detected
Echinacea purpurea plus Salvia officinalis lozenge (a combination)
unspecified Not shown here; see the study 4 days
One lozenge cut throat pain by 48% (p<0.001) and symptoms by 34% (p<0.001). In the 18 virus-positive patients, viral load fell 62% after one lozenge and 96% after 4 days.
Throat pain -48% after a single lozenge (no control group)
Methods, limits and funding

Outcomes: Throat pain and tonsillopharyngitis symptom diary; viral load by swab

Limitations: Combination product, so sage cannot be separated from Echinacea; no placebo; sore throats often settle on their own; only 18 had measurable virus; sponsored by the manufacturer.

Funding and conflicts: Sponsor A. Vogel AG; some authors are employees.

Read: abstract

Wightman 2021
The Acute and Chronic Cognitive Effects of a Sage Extract: A Randomized, Placebo Controlled Study in Healthy Humans.
Nutrients · PMID 33466627 · DOI
Controlled trial
94
Healthy adults aged 30 to 60 (25 men, 69 women)
CogniviaTM, a proprietary extract of Salvia officinalis polyphenols plus Salvia lavandulaefolia terpenoids
leaf (combination extract) Not shown here; see the study Acute (120 and 240 minutes after the first dose) and 29 days · vs Placebo (parallel groups)
A consistent benefit was seen on working memory and accuracy tasks (Corsi Blocks, Numeric Working Memory, Name to Face Recall), both on the first day and after 29 days.
Numbers not in the abstract.
Methods, limits and funding

Outcomes: Wide range of computerised cognitive tasks

Limitations: One trial of one branded combination; the authors say a follow-up is needed to see how this differs from either sage alone. Industry connection.

Funding and conflicts: Co-author affiliated with Nexira SAS (conflict of interest declared).

Read: abstract

Wilfried 2021
Effectiveness of Menosan® Salvia officinalis in the treatment of a wide spectrum of menopausal complaints. A double-blind, randomized, placebo-controlled, clinical trial.
Heliyon · PMID 33615001 · DOI
Controlled trial
80
Menopausal women aged 48 to 65
Menosan, a fresh-plant ethanol extract of Salvia officinalis (tablets)
fresh leaf (as stated: freshly harvested Salvia officinalis) Not shown here; see the study 4 weeks · vs Placebo
Menopause Rating Scale fell more than with placebo. The abstract reports a positive effect on sleep quality, discontent and fatigue (P < 0.05) and frontal-lobe EEG changes.
Menopause Rating Scale -39.2% (p = 0.002 vs placebo); sleep and mood numbers not in the abstract.
Methods, limits and funding

Outcomes: Menopause Rating Scale; hot flush score; EEG; sleep and mood questionnaires

Limitations: Sponsored by the manufacturer. Menopausal women only. Sleep and mood were secondary outcomes.

Funding and conflicts: Sponsored by A.Vogel; one author is an employee (declared).

Registration: EudraCT 2016-005033-77

Read: abstract

Zeidabadi 2020
The effect of Salvia officinalis extract on symptoms of flushing, night sweat, sleep disorders, and score of forgetfulness in postmenopausal women.
J Family Med Prim Care · PMID 32318472 · DOI
Controlled trial
66
Postmenopausal women with menopausal symptoms (Shiraz, Iran)
Salvia officinalis extract tablets
unspecified Not shown here; see the study 3 months · vs Placebo tablets
In the sage group, scores for sleep problems, depression, nervousness and anxiety dropped by 1.6, 1.4, 1.2 and 1.6 units compared with the control group (P < 0.001), and PSQI fell by 3.8 units (9.4 to 5.6, P < 0.05).
As stated in the abstract; confidence intervals not given.
Methods, limits and funding

Outcomes: Menopause Rating Scale items; Pittsburgh Sleep Quality Index (PSQI)

Limitations: Small trial in menopausal women, so results may not apply to other people. The PSQI drop is a within-group change as described in the abstract. Hot flush results are covered in the body file.

Read: abstract

s-ema-hmpc-salvia-officinalis-folium
EMA/HMPC: European Union herbal monograph on Salvia officinalis L., folium (EMA/HMPC/277152/2015) and Final assessment report on Salvia officinalis L., folium and aetheroleum (EMA/HMPC/150801/2015)
· Source
Authoritative guidance
n/a

Methods, limits and funding

Read: full-text

s-gbif-salvia-apiana
GBIF Backbone: Salvia apiana Jeps. (usageKey 2927016)
· Source
Reference database
n/a

Methods, limits and funding

Read: full-text

s-gbif-salvia-lavandulifolia
GBIF Backbone: Salvia lavandulifolia Spreng. (usageKey 7948017)
· Source
Reference database
n/a

Methods, limits and funding

Read: full-text

s-gbif-salvia-miltiorrhiza
GBIF Backbone: Salvia miltiorrhiza Bunge (usageKey 7308369)
· Source
Reference database
n/a

Methods, limits and funding

Read: full-text

s-gbif-salvia-officinalis
GBIF Backbone: Salvia officinalis L. (usageKey 2927004)
· Source
Reference database
n/a

Methods, limits and funding

Read: full-text

s-gbif-salvia-sclarea
GBIF Backbone: Salvia sclarea L. (usageKey 2927000)
· Source
Reference database
n/a

Methods, limits and funding

Read: full-text

s-ncbi-taxonomy-salvia
NCBI Taxonomy: Salvia officinalis (taxid 38868) and related Salvia species
· Source
Reference database
n/a

Methods, limits and funding

Read: full-text

s-pubchem-sage-compounds
PubChem PUG REST: compound lookups by name (CIDs and molecular formulae)
· Source
Reference database
n/a

Methods, limits and funding

Read: full-text

What we do not know yet

  • No trial of sage tea for memory, thinking or mood was found.
  • The Alzheimer's evidence is one 42-person trial from 2003 with no replication.
  • Most memory trials were single sessions in healthy volunteers, many from one research group; whether any benefit lasts or matters in daily life is unknown.
  • No trial of sage tea as a drink or gargle for hot flushes, sore throat, blood sugar or cholesterol; the only tea studies are a six-person pilot and mouth rinses.
  • Hot flush trials are short, with a strong placebo effect in this field, and the largest has no placebo; two of the five studies have authors at one maker.
  • The diabetes and cholesterol trials all come from Iran, two from one group, and none lasted more than 3 months.
  • No trial measured outcomes such as heart attacks or diabetes complications.
  • No trial has tested sage in people with epilepsy or a seizure history. Seizure warnings rest on animal work and a handful of case reports, mostly with oil.
  • The case reports EMA quotes (adult intensive-care poisonings, the toddler sage tea case, oil used for acne) were not read in the original.
  • No measurement of thujone in the blood of the people harmed; one 2018 study measured only urine breakdown products in volunteers who drank sage tea.
  • No rate for any adverse effect: the number of people who drink sage tea is unknown, so case reports cannot be turned into a risk.

How new research is added

New studies are found by a saved PubMed search and are placed in a review queue. A person reads each one before it changes any evidence rating or safety wording. New publications never change ratings automatically.

Lab markers

What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".

Metabolic 2

▼

Fasting blood glucose

Lowered in trials

Blood sugar after not eating overnight, measured in mg/dL.

Low certainty
Results and what it means

Why it was measured

Main outcome of the diabetes trials.

Statistical vs. clinical meaning

Large pooled fall in people with diabetes; none in healthy women drinking tea.

Safety implication

May add to diabetes medicines.

StudyResultPeopleProduct
2Mean difference -31.15 mg/dL (95% CI -37.56 to -24.73)3 trials in adults with type 2 diabetesSalvia officinalis leaf extract or tablets
62No effect on plasma glucose after 4 weeks of tea6 healthy women, non-randomised pilotSage tea

2 62

●

HbA1c (average blood sugar over about 3 months)

Lowered in 2 of 3 trials in trials

A blood test showing average blood sugar over roughly three months.

Low certainty
Results and what it means

Why it was measured

Standard long-term measure in diabetes trials.

Statistical vs. clinical meaning

Positive in the pooled analysis, null in one of the three trials.

Safety implication

Check with the prescriber when on diabetes medicine.

StudyResultPeopleProduct
2Mean difference -0.94 percentage points (95% CI -1.25 to -0.63)3 trials in adults with type 2 diabetesSalvia officinalis leaf extract or tablets
9No significant change in HbA1c or fasting glucose; after-meal glucose lower80 adults with type 2 diabetesSage tablets versus placebo, 3 months

2 9

Other 7

●

ADAS-cog score (a thinking test used in Alzheimer's trials)

Improved versus placebo in trials

A clinician-run test of memory, language and thinking; a lower score means better function.

Low certainty
Results and what it means

Why it was measured

Main outcome of the Alzheimer's trial.

Statistical vs. clinical meaning

A statistical difference in one small trial; its size in everyday terms is not given in the abstract.

Safety implication

None specific.

StudyResultPeopleProduct
5Better outcome than placebo at 4 months (F = 4.77, P = 0.03)42 adults aged 65 to 80 with mild to moderate Alzheimer'sSalvia officinalis liquid extract, 16 weeks

5

●

Clinical Dementia Rating, Sum of Boxes

Improved versus placebo in trials

A clinician rating of how much memory and thinking problems affect daily life.

Low certainty
Results and what it means

Why it was measured

Second main outcome of the Alzheimer's trial.

Statistical vs. clinical meaning

Agrees in direction with the ADAS-cog result, in the same single trial.

Safety implication

None specific.

StudyResultPeopleProduct
5Better outcome than placebo at 4 months (F = 10.84, P < 0.003)42 adults aged 65 to 80 with mild to moderate Alzheimer'sSalvia officinalis liquid extract, 16 weeks

5

●

Secondary memory (recall of words and pictures after a delay)

Improved at one tested amount in trials

A computerised memory test battery measuring how well people remember new information.

Low certainty
Results and what it means

Why it was measured

Main outcome in the older-adults extract trial.

Statistical vs. clinical meaning

A same-day effect in 20 people; lasting benefit was not tested.

Safety implication

None specific.

StudyResultPeopleProduct
61Improved at all test times for one of the four tested amounts versus placebo; the other amounts helped less20 healthy adults over 65Standardised Salvia officinalis extract, single sessions

61

●

Working memory and accuracy tasks

Improved in trials

Tests such as Corsi Blocks and Numeric Working Memory that measure holding and using information for a short time.

Low certainty
Results and what it means

Why it was measured

Main outcomes in the 29-day combination extract trial.

Statistical vs. clinical meaning

Industry-linked trial of a two-species combination extract; not tea.

Safety implication

None reported in the abstract.

StudyResultPeopleProduct
72Consistent significant benefit on working memory and accuracy tasks, acutely and across 29 days94 adults aged 30 to 60Combination extract of Salvia officinalis and Spanish sage versus placebo, 29 days

72

▼

Hot flush score (diary-rated frequency and intensity)

Lowered in trials

A woman's own diary of how many flushes she has and how strong they are.

Low certainty
Results and what it means

Why it was measured

Main outcome of the menopause trials.

Statistical vs. clinical meaning

Self-reported scores with a strong placebo effect in this field; the pooled range is wide.

Safety implication

Hormone-sensitive conditions: ask a doctor first.

StudyResultPeopleProduct
11Intensity-rated flush score down 50% by week 4 and 64% by week 8 (P<0.0001); no placebo group71 women, at least 5 flushes a dayFresh sage leaf tablet, 8 weeks
73Hot flush score down 55.3% (significant from week 3, p = 0.028); Menopause Rating Scale down 39.2%, better than placebo (p = 0.002)80 women aged 48 to 65Fresh-sage ethanol extract tablets versus placebo, 4 weeks
45Frequency ES -1.12 (95% CI -2.37 to 0.14); severity ES -2.05 (95% CI -6.53 to 2.43)4 trials, 310 womenSalvia officinalis (various preparations)

11 73 45

▼

LDL and total cholesterol

Lowered in trials

Blood fats linked to heart disease risk.

Low certainty
Results and what it means

Why it was measured

Main outcomes of the blood fat trials.

Statistical vs. clinical meaning

Stand-in measures; no heart outcomes studied.

Safety implication

Mention to your doctor if on a statin.

StudyResultPeopleProduct
2Total cholesterol -43.64 mg/dL (95% CI -83.26 to -4.02) in the pooled analysis3 trials in type 2 diabetesSalvia officinalis leaf extract
33Total cholesterol, triglyceride, LDL and VLDL lower and HDL higher than placebo67 adults with high blood fatsSage leaf extract capsules versus placebo, 2 months
62Lower LDL and total cholesterol and higher HDL during and 2 weeks after the tea; no control group6 healthy womenSage tea, 4 weeks

2 33 62

▼

Throat pain intensity

Lowered in trials

A patient-rated scale of how sore the throat is.

Low certainty
Results and what it means

Why it was measured

Main outcome of the spray and lozenge trials.

Statistical vs. clinical meaning

Short-term relief in trials with company links; combination product in one.

Safety implication

See a doctor if symptoms last more than a few days.

StudyResultPeopleProduct
26The 15% sage spray was significantly better than placebo over the first 2 hours after the first use (no numbers in the abstract)286 adults with viral pharyngitisSage fluid-extract spray versus placebo, 3 days
60Response rate 63.8% with Echinacea and sage versus 57.8% with chlorhexidine and lidocaine154 people aged 12 and overEchinacea and sage spray versus chlorhexidine and lidocaine spray

26 60

Safety

What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.

Main points to know 9
  • Sage tea contains thujone, a natural substance that is toxic to the brain at high intake, and tea strength varies a lot. Sage leaf contains thujone. In animals it blocks the brain's main calming (GABA-A) receptors and can cause convulsions at high doses. The EU regulator (EMA) reports no case of overdose from sage leaves themselves and lists undesirable effects of the leaf as none known, but it sets a daily ceiling on thujone from sage leaf medicines and a maximum of 2 weeks at that ceiling. EMA's figures come from animal studies on thujone alone, not from sage tea in people. In a survey of 108 sage products, the thujone in teas ranged from not detectable to more than 37 mg per litre, and in alcohol tinctures it was far higher. A second survey found medicinal teas averaged more than twice the thujone of food teas, and brewing for longer than about 5 minutes did not add more. So a cup of sage tea can hold very different amounts depending on the product. Authoritative guidance 18 20 19 70 69 37
  • EMA limits how long sage leaf should be used without seeing a doctor. The EU herbal monograph (2016) lists sage leaf, including as a herbal tea, as a traditional medicine only, meaning it rests on long use and not on modern trial proof. It says to see a doctor if indigestion symptoms last longer than 2 weeks, if mouth or throat symptoms last longer than 1 week, if skin symptoms last longer than 2 weeks, and if sweating has not improved within 6 weeks. EMA's separate public statement on the thujone ceiling says the thujone allowance for sage leaf preparations applies for a maximum duration of 2 weeks. Sage tea drunk daily for months is outside what has been assessed. Authoritative guidance 18 19
  • Never swallow sage essential oil; seizures have been reported, including in a baby and a young child. Sage essential oil is concentrated. EMA reports that swallowing sage oil in an amount equal to a large quantity of sage leaf has caused a sensation of heat, a fast heartbeat, dizziness and seizures. A case report describes generalised seizures in a 33-day-old given sage oil for colic and in a 5-year-old who took sage oil for tummy pain; both recovered, and no other cause was found. EMA concluded in 2010 that the benefit-risk balance of sage oil as a single-ingredient medicine is negative. Oil is not tea, but the same plant and the same substance are involved. Case report 23 19 20 18
  • People with epilepsy or any seizure history should avoid medicinal amounts of sage, and ask a doctor even about regular tea. EMA's assessment report quotes a case of an 18-month-old girl who had vomiting and diarrhoea and was given a tea made from a home-grown herb that a botanist identified as sage; two hours later she had a seizure and 18 hours later three more, and the authors suggest the tea may have brought out a seizure tendency that was already there. It is one case, and the amount of sage and thujone is unknown. The German Commission E, as quoted by EMA, warns that seizures can occur after prolonged use of alcoholic sage extracts or the pure oil. No trial has tested sage in people with epilepsy. Case report 20 21 56 49
  • Pregnancy and breastfeeding: not recommended. EMA says safety in pregnancy and breastfeeding has not been established and use is not recommended; no fertility data exist. The EMA report also quotes older reference books that call sage contraindicated in pregnancy and describe thujones as able to end a pregnancy and bring on a period. We found no study that proves this in women. The US LactMed database, as we could read it, says there is no safety data for nursing mothers or infants and that sage is traditionally used to reduce milk supply, but no study tested that. In a hospital survey of 300 Palestinian women, sage was one of the most used herbs and pregnancy outcomes did not differ from non-users, but this self-report survey cannot show safety. In mice, sage oil in feed changed early-embryo cell counts in a negative direction, a small animal finding. Authoritative guidance 18 20 47 6 16
  • Children and teenagers: oral use is not recommended. EMA says use under 18 has not been established because of a lack of adequate data. Two small children had seizures after sage oil. Sprays were tested in people aged 12 and over; no trial of sage tea in children was found. Authoritative guidance 18 23 60
  • Sage may add to the effect of diabetes medicines. Three small trials in people with type 2 diabetes found lower blood sugar on sage leaf extract than on placebo (in one, people were already on glyburide, metformin and atorvastatin), and a 2023 pooled analysis of the three found a fall in fasting sugar and HbA1c. These used extracts, not tea. EMA left blood-sugar effects out of its monograph because it judged the evidence limited. Abstracts report no adverse effects but do not say whether low blood sugar was specifically checked. If you take diabetes medicine, tell your doctor or pharmacist before using sage regularly and watch your readings. Controlled trial 34 35 9 2 20
  • Estrogen-like activity is shown in the lab and in rats, not proven in women. A sage extract raised uterus weight in young rats with their ovaries removed. In cell tests a fraction of one sage extract showed estrogen-like activity, though the whole tincture did not. In 8 women in a small 1998 study of a sage and alfalfa product, resting estradiol, LH and FSH did not change. No study followed breast or womb tissue in women. People with hormone-sensitive conditions, for example some breast cancers, should ask their doctor before regular medicinal use. Pharmacological theory 58 54 15
  • Short trials report few problems, but nothing long-term has been studied. In a 4-week placebo trial of a fresh-sage extract in 80 menopausal women, three adverse events occurred in total and none was linked to the treatment. Trials of 2 to 3 months in people with diabetes reported no adverse effects. Sprays caused mild dry throat or burning. These trials used extracts, not tea, lasted days to 4 months, and most did not describe safety in detail. A six-person pilot of sage tea for 4 weeks saw no liver or other side effects, which is too small to prove safety. Controlled trial 73 34 35 26 62
Side effects 7
EffectHow oftenSeverity and recoveryEvidence
Seizures after swallowing sage essential oil
Cases come from accidental or home use of the oil in a newborn and a young child. EMA also cites adult intensive-care poisonings (Millet 1981) that we could not read in the original. No rate is known.
Not establishedserious
Both children in the cited report recovered; one had repeated seizures
Case report 23 20 19
Seizures after sage tea in a toddler
One 18-month-old with vomiting and diarrhoea (Tong 2003, as reported in the EMA assessment report). The original case was not read, and the amount of sage and thujone is unknown.
Not establishedserious
Treated in hospital; doctors suggested the tea may have unmasked a seizure tendency
Case report 20
Heat sensation, fast heartbeat and dizziness
EMA lists these as reported after sage oil, in an amount corresponding to a large quantity of leaf, before seizures.
Not establishedmoderate
Not stated
Authoritative guidance 18
Mild dry throat or burning with sage spray
In a trial of 286 adults with sore throat, only minor side effects of this kind were reported, with no counts in the abstract.
Not establishedmild
Presumed reversible
Controlled trial 26
Skin irritation or allergic skin reaction
EMA calls sage oil a moderate skin irritant and not recommended for aromatherapy. The patch-test figure is quoted by EMA from a 1993 study; a reaction at only one concentration may be irritation rather than true allergy.
Sage gave a positive patch-test result at one concentration in 2 of 55 patients tested for spice allergymild
Presumed reversible
Authoritative guidance 20
Low blood sugar when combined with diabetes medicines
Sage extract lowered blood sugar in diabetes trials. Trials did not report low-sugar episodes, but the abstracts do not say they were looked for.
Not establishedmoderate
Not applicable
Pharmacological theory 35 34 2
Few problems in several small trials
Trials in menopause, diabetes and Alzheimer's disease reported none or very few problems. They were small, short, and several did not describe safety in detail.
3 adverse events in 80 women over 4 weeks, none treatment-relatednot applicable
Not applicable
Controlled trial 73 34 35 5
Liver

We found no published human case of liver injury caused by sage in the sources read. In the diabetes trials that measured liver enzymes, results did not differ from placebo. In mice, sage tea given before the liver poison carbon tetrachloride made the injury worse and raised a liver enzyme (CYP2E1), although the tea alone was not toxic; the authors warn of possible interactions with medicines cleared by the liver. We could not find an NIH LiverTox entry for sage, so no LiverTox likelihood score is given. 34 35 2 40 62

How often. No frequency of human liver injury was found. Not finding reports is not proof that none exist; the trials were of 80 to 100 people.

Monitoring. No agency monitoring advice was found. Anyone with liver disease should ask a doctor first, especially for alcohol-based tinctures. Stop and seek care for yellow skin or eyes, dark urine, pale stools or severe itching.

This is a safety connection. It is not evidence that Sage Tea supports liver health.

Medicines and supplements 7
WithWhy it mattersImportanceEvidenceWhat to do
Anti-seizure medicines
prescription
Theory: thujone blocks GABA-A receptors in animals and cells, the same calming system many anti-seizure medicines support. In test tubes, sage leaf compounds also bound to the benzodiazepine site of this receptor.EMA lists no interactions as reported, and no interaction with anti-seizure medicines has been documented in people. The concern rests on mechanism and on seizure case reports.Pharmacological theory Very low certainty 18 20 56 30If you take anti-seizure medicine, do not add medicinal sage or sage tincture without your neurologist or pharmacist knowing, and ask about regular tea.
Diabetes medicines (for example glyburide, metformin, insulin)
prescription
Sage extract lowered blood sugar in people with type 2 diabetes. This could add to the medicine's effect.In a 100-person trial, sage extract was added to glyburide, metformin and atorvastatin and lowered glucose and HbA1c further than placebo, with no adverse effect reported. The abstract does not say whether low-sugar episodes were checked.Controlled trial Low certainty 35 34 9 2If you take diabetes medicine, tell your doctor before using sage regularly and check blood sugar as advised. Do not change your medicine yourself.
Sedatives, sleeping pills and benzodiazepines
prescription
Lab only: sage flavones and diterpenes bound the benzodiazepine receptor in test tubes.No study tested sage with sedatives in people, and the trials we read did not report drowsiness. The effect in people is unknown.Laboratory research Very low certainty 30If you take sedatives or sleep medicines, ask your pharmacist before regular medicinal use of sage.
Medicines broken down by liver enzymes (CYP2C19 and others)
prescription
In cultured human liver cells a common sage product raised CYP2C19 activity as concentration rose and showed a general inhibitory effect on other CYP enzymes; in mice, sage tea raised CYP2E1.No human interaction study. The authors of the cell work name sage as a possible candidate for interaction with CYP2C19 drugs, though they point to St John's wort, ginkgo and valerian as the likelier ones.Laboratory research Very low certainty 25 24 40If you take a medicine with a narrow safety margin, ask your pharmacist before regular use of sage in medicinal amounts.
Hormone medicines (menopausal hormone therapy, anti-estrogen medicines such as tamoxifen)
prescription
Theory: estrogen-like effects were seen in rats and in one cell test.No study has looked at sage with hormone therapy or breast cancer medicines.Pharmacological theory Very low certainty 58 54 15If you have a hormone-sensitive condition or take such medicine, ask your doctor before regular medicinal use.
Other thujone sources (wormwood, tansy, thuja, absinthe, sage oil)
herb
Thujone adds up across products.EMA's thujone ceiling counts all sources. Combining several thujone-rich products could pass it. No combination study has been done.Pharmacological theory Low certainty 19 49 53Do not stack several thujone-rich herbs or oils. Check the labels of teas and tinctures.
Alcohol (tinctures and liquid extracts)
otc
Sage tinctures and some liquid extracts are made with ethanol (EMA lists tincture and extract solvents of 31.5% to 70% ethanol). Tea is made with water. Tinctures also carry more thujone than tea.EMA requires alcohol labelling on ethanol-containing sage medicines.Authoritative guidance Moderate certainty 18 70People avoiding alcohol, with liver disease or on sedatives should ask a pharmacist before choosing a tincture.
Who should check first 10
SituationAdviceEvidence
Allergy to sage or a past reaction to a sage productDo not use. The EU monograph lists hypersensitivity to the active substance as the only contraindication.Authoritative guidance 18
Epilepsy, past seizures or an unexplained seizureAvoid sage oil, tinctures and medicinal amounts. Ask your doctor even about regular tea. This rests on mechanism and case reports, not on a trial.Case report 20 23 56
Anyone swallowing sage essential oil (including children, who may drink it by accident)Do not swallow the oil. Keep it out of children's reach. EMA concluded the benefit-risk balance of sage oil is negative.Authoritative guidance 19 23
PregnancyNot recommended (EMA): safety not established. Older references describe thujone as able to end a pregnancy, which is unproven in women.Authoritative guidance 18 20
BreastfeedingNot recommended (EMA). LactMed found no safety data, and sage is traditionally used to reduce milk supply, which was not tested in a study.Authoritative guidance 47 18
Children and teenagers under 18Oral use is not recommended (EMA). Two small children had seizures after sage oil.Authoritative guidance 18 23
Taking diabetes medicinesAsk your doctor first and monitor blood sugar; sage extract lowered blood sugar in trials.Controlled trial 35 2
Hormone-sensitive conditions (for example some breast, womb or ovarian cancers, endometriosis)Ask your doctor before regular medicinal use. Estrogen-like activity was seen in rats and cells; its effect in women is unknown.Pharmacological theory 58 54
Liver disease, or a need to avoid alcohol (for alcohol-based tinctures)No human liver case reports were found, but data are scarce. Choose non-alcohol forms and ask your doctor.Pharmacological theory 40 18
Planned surgeryTell the surgical team about regular medicinal use of sage, because it may lower blood sugar. This is a precaution based on the diabetes trials, not a documented problem.Pharmacological theory 2
Overdose, product quality and regulators

Summary. The toxic part of sage is its essential oil and strong alcoholic extracts, which are rich in thujone and camphor. Sage leaf as tea or food has low reported toxicity, with no overdose reported to EMA. A large drink of strong tea has not been reported to cause poisoning in the sources we read, but tea strength varies and the single toddler case suggests a risk for people prone to seizures.

Animal. EMA, quoting ESCOP, reports that sage oil caused convulsions in rats at high doses and deaths at much higher ones. A US long-term toxicology study analysed by Lachenmeier gave a lower confidence bound at which 10% of male rats had clonic seizures; female rats and mice are more sensitive because thujone reaches the brain at higher levels. A statistical study found other oil components, not only thujone, also contributed to toxicity and behaviour effects in rats.

Human doses studied. Trials gave sage as extract tablets or capsules for 4 weeks to 4 months, as drops for 4 months in Alzheimer's disease, as a fresh-leaf tablet for 8 weeks, as sprays and rinses for days to 12 weeks, and as tea only in a six-person 4-week pilot. None reported serious problems in the abstracts. This describes what was studied, not what to take.

High dose or long term signals. EMA says seizures can follow prolonged use of alcoholic extracts or the pure oil. No long-term study of sage tea was found beyond the 4-week pilot. A mouse study found 2 weeks of sage tea made carbon-tetrachloride liver injury worse.

Overdose response. Sage leaf: no overdose reported (EMA). Sage oil: sense of heat, fast heartbeat, dizziness and seizures reported. If someone, especially a child, swallows sage oil or has a seizure after a sage product, call emergency services or your local poison centre at once.

Genotoxicity. Data are lacking: EMA says adequate tests on genotoxicity and carcinogenicity have not been performed for the monograph preparations, and reproductive toxicity tests have not been performed.

Toxic or hazardous parts. Essential oil (distilled from the leaves) and strong alcoholic extracts are the concern. Leaf as tea or in food is the traditional form.

Quality is the main issue: the thujone content of sage tea, tinctures, oils and supplements varies enormously, and sage is often misidentified. We found no survey of pesticides or heavy metals in retail sage tea.

Thujone varies widely between teas and tinctures. In 108 products, thujone in teas ranged from not detectable to 37.5 mg per litre, and in tinctures to 409 mg per litre. A second survey found food teas averaged 4.4 mg per litre and medicinal teas 11.3 mg per litre, and that aqueous teas recovered only about a third of the thujone that a strong alcohol extract gave. 70 69 7

Supplements labelled for menopause can have no thujone. Four commercial sage supplements sold for menopause had no detectable thujone or isoflavones, and their polyphenol levels differed by up to 1.8 to 3.2 times. The product bought may differ from the sage used in trials. 41

Other Salvia species and adulteration. LactMed, as we could read it, says sage is often misidentified or adulterated. Garden sage (Salvia officinalis) is not clary sage, danshen, white sage or Spanish sage; safety findings do not transfer between them. 47

Caffeine. Sage is not from the tea plant (Camellia sinensis). A lab analysis of 33 non-Camellia teas found no caffeine, theobromine or theophylline in any of them, but its abstract does not list sage by name, so this is indirect. 10

BodyActionDate
European Medicines Agency, Committee on Herbal Medicinal Products (HMPC) (European Union)Herbal monograph on sage leaf (EMA/HMPC/277152/2015): traditional use only, for mild indigestion, excessive sweating, mouth and throat inflammation and minor skin inflammation. Contraindication: hypersensitivity. Not recommended under 18. Pregnancy and breastfeeding: safety not established, not recommended. Interactions: none reported. Undesirable effects: none known. Overdose: none from sage leaf; sage oil in an amount equal to a large quantity of leaf is reported to cause heat, fast heartbeat, dizziness and seizures. Thujone: the amount in a product must be specified and daily exposure kept under the stated ceiling. source2016-09-20
European Medicines Agency, Committee on Herbal Medicinal Products (HMPC) (European Union)Public statement on sage essential oil: the benefit-risk analysis of sage oil as a single-ingredient traditional medicine is negative. Sage oil is rich in thujone and may cause seizures at high doses. The thujone allowance for sage leaf preparations applies for a maximum duration of 2 weeks. source2016-02-02
European Medicines Agency, HMPC assessment report (European Union)Assessment report on sage leaf and sage oil: reports the toddler seizure case after sage tea, the oil seizure cases, a skin patch test figure, older references on pregnancy, and says hypoglycaemic effects were left out of the monograph because of limited evidence. source2016
When to get medical help
  • A seizure, convulsion or a child who is limp or unresponsive after any sage product, especially sage oil: call emergency services now. Do not wait to see if it passes.
  • Anyone, especially a child, who swallows sage essential oil: call emergency services or your local poison centre right away, even if they seem well.
  • Racing heart, strong feeling of heat, severe dizziness or confusion after sage tea, tincture or oil: stop and get medical care promptly.
  • Very shaky, sweaty, confused or faint (possible low blood sugar) while using sage with diabetes medicines: treat as your diabetes plan says and call your doctor.
  • Yellow skin or eyes, dark urine, pale stools or severe itching: stop sage and see a doctor the same day.
  • Rash, swelling of the face or lips, or trouble breathing after a sage product: stop and seek emergency care (possible allergic reaction).
  • Pregnant, or think you may be: stop medicinal sage and ask your doctor. Vaginal bleeding or cramps in pregnancy: call your doctor or emergency services.

Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.

General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.

Frequently asked questions

Does sage tea help hot flushes?

It might, but the evidence is low certainty and it is not from tea. Four small trials of sage extract tablets (310 women in a pooled review) all reported fewer or milder flushes, but the pooled range of results was wide, only two trials had a placebo group, and two had authors at the maker of the fresh-sage product. Nobody has tested sage tea for hot flushes.

45 11 73 74

Does sage tea help a sore throat?

Sage throat sprays eased pain for a short time in trials, but sage tea itself has not been tested. A 15% sage extract spray beat placebo for pain in the first two hours in 286 people, and a sage and Echinacea spray worked about as well as a chlorhexidine and lidocaine spray in another trial, but that was a combination product. Sore throats often get better by themselves. See a doctor if it lasts more than a few days or comes with high fever.

26 60 71

Does sage tea improve memory?

No trial has tested sage tea for memory. Small trials of sage leaf extracts and capsules improved some memory and attention tests for a few hours in healthy adults, and one 42-person trial in mild to moderate Alzheimer's disease reported better scores on a liquid extract. All are low certainty, and the one 29-day trial of a two-species extract has an industry link.

61 72 5 42

Can sage tea lower blood sugar or cholesterol?

Sage extract capsules lowered blood sugar and cholesterol in three small Iranian trials in people with type 2 diabetes, and a pooled analysis agrees. Sage tea was tried only in a six-person pilot in healthy women, which found no change in blood sugar and better cholesterol numbers without a control group. It is not a replacement for diabetes treatment, and it can add to diabetes medicines.

2 34 9 35 62

Does sage tea contain caffeine?

Sage is not from the tea plant, so it is not a source of tea caffeine. A lab analysis of 33 herbal teas that were not from Camellia found no caffeine in any, but its abstract does not name sage, so this is indirect. Blends sold as sage tea may add other ingredients, so read the label.

10

What is thujone and should I worry about it?

Thujone is a natural substance in sage leaf that blocks the brain's calming (GABA-A) receptors in animals and can cause seizures at high intake. Tea has far less than tinctures or oil, but the amount in tea varies a lot between products. EMA reports no overdose from sage leaf itself. The concern is greatest for people with seizure disorders, for oil and tinctures, and for combining several thujone-rich products.

49 70 69 37 18

How long is it safe to drink sage tea?

Nobody has proved a safe length of time, and no study followed sage tea beyond 4 weeks. The EU monograph says to see a doctor if indigestion symptoms last longer than 2 weeks, mouth or throat symptoms longer than 1 week, or sweating has not improved after 6 weeks. EMA's thujone allowance for sage leaf medicines applies for a maximum of 2 weeks.

18 19

Is sage tea safe in pregnancy or while breastfeeding?

EMA says safety has not been established and use is not recommended in either. Older books call thujone able to end a pregnancy, which has not been proven in women. Sage is traditionally used to dry up breast milk, but no study tested whether it works, and it could reduce milk when you do not want that.

18 20 47

Who should avoid sage tea?

Anyone allergic to sage, people with epilepsy or past seizures (ask a doctor even about tea), children and teenagers under 18, and people who are pregnant or breastfeeding. People taking diabetes, sedative, anti-seizure or hormone medicines, or with a hormone-sensitive condition or liver disease, should ask a doctor or pharmacist first.

18 20 56 58

Does sage tea interact with medicines?

Possibly. Sage extract lowered blood sugar in trials, so it may add to diabetes medicine. Lab work suggests it could affect liver enzymes that process some medicines and bind the same brain receptor as sedatives, but there are no human interaction studies. EMA lists no interactions as reported.

35 25 24 30 18

Is sage tea the same as sage extract, capsules or sage oil?

No. Tea is the leaf steeped in water. Extracts and capsules are concentrated and used in most trials, tinctures are made with alcohol and carry more thujone, and sage oil is a distilled oil that should never be swallowed. EMA judged the benefit-risk balance of sage oil negative. Results from one form should not be assumed for another.

70 69 19 23

Is sage tea the same as white sage or clary sage?

No. Garden sage (Salvia officinalis) is a different plant from clary sage, white sage, danshen and Spanish sage. Their chemistry differs, so research and safety findings do not transfer between them.

79 77

Explore by health goal

Memory SupportCognitive PerformanceWomens WellnessMental ClarityMenopause SupportHormone BalanceMetabolic HealthBetter FocusBrain HealthHealthy SkinImmune SupportInflammation BalanceDigestive SupportHealthy AgingBlood Sugar BalanceCholesterol BalanceHeart Health

Editorial transparency
Written by
AlternativeMed editorial team. Research compiled with AI assistance, then checked against PubMed records.
Medical review
None. This page has not been reviewed by a physician or pharmacist.
First published
2026-10-25
Last substantive update
2026-10-25
How we research
We searched PubMed, downloaded and read the EMA herbal monograph, public statement and the safety sections of the assessment report, and checked plant-name databases. Only abstracts were read for most studies. LactMed, the FDA listing and the German Commission E text were not re-opened for this page and are marked not verified. Certainty ratings are the compiler's own reading, not formal grades, unless a review's own grade is quoted. No study is cited that we could not verify.
How we rate evidence
See "How we rate evidence" in the Evidence tab.
Independence
No product is promoted on this page. No affiliate links are shown. If one is added later it will be labelled and kept apart from the evidence.
Sources 82

Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.

  1. Abdnezhad R, Simbar M, Sheikhan Z, et al.. [Salvia officinalis Reduces the Severity of the Premenstrual Syndrome].. Complement Med Res. 2019. PMID 30572339. DOI 10.1159/000490104. (abstract)
  2. Abdollahi A, Adelibahram F, Ghassab-Abdollahi N, et al.. The effect of Salvia officinalis on blood glycemic indexes and blood lipid profile in diabetic patients: a systematic review and meta-analysis.. J Complement Integr Med. 2023. PMID 35106985. DOI 10.1515/jcim-2021-0425. (abstract)
  3. Achour M, Bravo L, Sarriá B et al.. Bioavailability and nutrikinetics of rosemary tea phenolic compounds in humans. Food Res Int. 2021. PMID 33509454. DOI 10.1016/j.foodres.2020.109815. (human)
  4. Ahmad S, Ahmed SB, Khan A, et al.. Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials.. Metab Brain Dis. 2023. PMID 35960461. DOI 10.1007/s11011-022-01063-9. (abstract)
  5. Akhondzadeh S, Noroozian M, Mohammadi M, et al.. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.. J Clin Pharm Ther. 2003. PMID 12605619. DOI 10.1046/j.1365-2710.2003.00463.x. (abstract)
  6. Al-Ramahi R, Jaradat N, Adawi D. Use of herbal medicines during pregnancy in a group of Palestinian women.. J Ethnopharmacol. 2013. PMID 23933314. DOI 10.1016/j.jep.2013.07.041. (abstract)
  7. Arceusz A, Occhipinti A, Capuzzo A et al.. Comparison of different extraction methods for the determination of α- and β-thujone in sage (Salvia officinalis L.) herbal tea.. J Sep Sci. 2013. PMID 23843295. DOI 10.1002/jssc.201300206. (abstract)
  8. Beheshti-Rouy M, Azarsina M, Rezaie-Soufi L, et al.. The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial.. Iran J Microbiol. 2015. PMID 26668706. (abstract)
  9. Behradmanesh S, Derees F, Rafieian-Kopaei M. Effect of Salvia officinalis on diabetic patients.. J Renal Inj Prev. 2013. PMID 25340127. DOI 10.12861/jrip.2013.18. (abstract)
  10. Bi W, He C, Ma Y, et al. Investigation of free amino acid, total phenolics, antioxidant activity and purine alkaloids to assess the health properties of non-Camellia tea.. Acta Pharm Sin B. 2016. PMID 27006902. DOI 10.1016/j.apsb.2015.11.003. (abstract)
  11. Bommer S, Klein P, Suter A. First time proof of sage's tolerability and efficacy in menopausal women with hot flushes.. Adv Ther. 2011. PMID 21630133. DOI 10.1007/s12325-011-0027-z. (abstract)
  12. Christensen KB, Jørgensen M, Kotowska D et al.. Activation of the nuclear receptor PPARγ by metabolites isolated from sage (Salvia officinalis L.). J Ethnopharmacol. 2010. PMID 20696231. DOI 10.1016/j.jep.2010.07.054. (Test-tube result only. Does not show that sage lowers blood sugar in people through this route; authors say the antidiabetic activity 'could in part be mediated' by it.)
  13. Cutillas AB, Carrasco A, Martinez-Gutierrez R et al.. Composition and Antioxidant, Antienzymatic and Antimicrobial Activities of Volatile Molecules from Spanish Salvia lavandulifolia (Vahl) Essential Oils. Molecules. 2017. PMID 28825692. DOI 10.3390/molecules22081382. (in-vitro)
  14. Czyzewska MM, Mozrzymas JW. Monoterpene α-thujone exerts a differential inhibitory action on GABA(A) receptors implicated in phasic and tonic GABAergic inhibition. Eur J Pharmacol. 2013. PMID 23376563. DOI 10.1016/j.ejphar.2013.01.032. (in-vitro)
  15. De Leo V, Lanzetta D, Cazzavacca R, et al.. [Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent].. Minerva Ginecol. 1998. PMID 9677811. (abstract)
  16. Domaracký M, Rehák P, Juhás S et al.. Effects of selected plant essential oils on the growth and development of mouse preimplantation embryos in vivo.. Physiol Res. 2007. PMID 16497088. DOI 10.33549/physiolres.930929. (abstract)
  17. Doolaege EH, Raes K, De Vos F et al.. Absorption, distribution and elimination of carnosic acid, a natural antioxidant from Rosmarinus officinalis, in rats. Plant Foods Hum Nutr. 2011. PMID 21751091. DOI 10.1007/s11130-011-0233-5. (animal)
  18. EMA Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Salvia officinalis L., folium (sage leaf). EMA/HMPC/277152/2015. 2016. (full-text)
  19. EMA Committee on Herbal Medicinal Products (HMPC). Public statement on Salvia officinalis L., aetheroleum (sage oil). EMA/HMPC/41843/2009 Corr. 1. 2016. (full-text)
  20. EMA Committee on Herbal Medicinal Products (HMPC). Assessment report on Salvia officinalis L., folium and Salvia officinalis L., aetheroleum. EMA/HMPC/150801/2015. 2016. (full-text (safety sections))
  21. German Commission E (as cited in EMA/HMPC/150801/2015). German Commission E monograph on sage leaf (Salviae folium), as quoted by EMA. Commission E (cited in EMA assessment report). 1990. (summary-only (quoted by EMA))
  22. Ghorbani A, Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J Tradit Complement Med. 2017. PMID 29034191. DOI 10.1016/j.jtcme.2016.12.014. (mixed)
  23. Halicioglu O, Astarcioglu G, Yaprak I et al.. Toxicity of Salvia officinalis in a newborn and a child: an alarming report.. Pediatr Neurol. 2011. PMID 21907890. DOI 10.1016/j.pediatrneurol.2011.05.012. (abstract)
  24. Hellum BH, Hu Z, Nilsen OG. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.. Basic Clin Pharmacol Toxicol. 2007. PMID 17214607. DOI 10.1111/j.1742-7843.2007.00011.x. (abstract)
  25. Hellum BH, Hu Z, Nilsen OG. Trade herbal products and induction of CYP2C19 and CYP2E1 in cultured human hepatocytes.. Basic Clin Pharmacol Toxicol. 2009. PMID 19371257. DOI 10.1111/j.1742-7843.2009.00412.x. (abstract)
  26. Hubbert M, Sievers H, Lehnfeld R, et al.. Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis.. Eur J Med Res. 2006. PMID 16504956. (abstract)
  27. Höld KM, Sirisoma NS, Ikeda T et al.. Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proc Natl Acad Sci U S A. 2000. PMID 10725394. DOI 10.1073/pnas.070042397. (animal)
  28. Höld KM, Sirisoma NS, Casida JE. Detoxification of alpha- and beta-Thujones (the active ingredients of absinthe): site specificity and species differences in cytochrome P450 oxidation in vitro and in vivo. Chem Res Toxicol. 2001. PMID 11368559. DOI 10.1021/tx000242c. (animal)
  29. Jinhua W. Ursolic acid: Pharmacokinetics process in vitro and in vivo, a mini review. Arch Pharm (Weinheim). 2019. PMID 30663087. DOI 10.1002/ardp.201800222. (mixed)
  30. Kavvadias D, Monschein V, Sand P et al.. Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor.. Planta Med. 2003. PMID 12624814. DOI 10.1055/s-2003-37712. (abstract)
  31. Kennedy DO, Pace S, Haskell C, et al.. Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery.. Neuropsychopharmacology. 2006. PMID 16205785. DOI 10.1038/sj.npp.1300907. (abstract)
  32. Kennedy DO, Dodd FL, Robertson BC, et al.. Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults.. J Psychopharmacol. 2011. PMID 20937617. DOI 10.1177/0269881110385594. (abstract)
  33. Kianbakht S, Abasi B, Perham M, et al.. Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial.. Phytother Res. 2011. PMID 21506190. DOI 10.1002/ptr.3506. (abstract)
  34. Kianbakht S, Dabaghian FH. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial.. Complement Ther Med. 2013. PMID 24050577. DOI 10.1016/j.ctim.2013.07.004. (abstract)
  35. Kianbakht S, Nabati F, Abasi B. Salvia officinalis (Sage) Leaf Extract as Add-on to Statin Therapy in Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Clinical Trial.. Int J Mol Cell Med. 2016. PMID 27942500. (abstract)
  36. Krol A, Kokotkiewicz A, Luczkiewicz M. White Sage (Salvia apiana)-a Ritual and Medicinal Plant of the Chaparral: Plant Characteristics in Comparison with Other Salvia Species. Planta Med. 2022. PMID 33890254. DOI 10.1055/a-1453-0964. (mixed)
  37. Lachenmeier DW, Uebelacker M. Risk assessment of thujone in foods and medicines containing sage and wormwood--evidence for a need of regulatory changes?. Regul Toxicol Pharmacol. 2010. PMID 20727933. DOI 10.1016/j.yrtph.2010.08.012. (abstract)
  38. Li ZM, Xu SW, Liu PQ. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 2018. PMID 29698387. DOI 10.1038/aps.2017.193. (mixed)
  39. Lile IE, Samoilă AOJ, Cojocariu C, et al.. Comparative Clinical Evaluation of Chamomile, Sage, and Ginger Mouthwashes in Reducing Plaque and Gingival Inflammation.. Antibiotics (Basel). 2026. PMID 42192655. DOI 10.3390/antibiotics15050433. (abstract)
  40. Lima CF, Fernandes-Ferreira M, Pereira-Wilson C. Drinking of Salvia officinalis tea increases CCl(4)-induced hepatotoxicity in mice.. Food Chem Toxicol. 2007. PMID 17084954. DOI 10.1016/j.fct.2006.09.009. (abstract)
  41. Maggini V, Bertazza G, Gallo E et al.. The Different Phytochemical Profiles of Salvia officinalis Dietary Supplements Labelled for Menopause Symptoms.. Molecules. 2023. PMID 38202677. DOI 10.3390/molecules29010094. (abstract)
  42. Miroddi M, Navarra M, Quattropani MC, et al.. Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease.. CNS Neurosci Ther. 2014. PMID 24836739. DOI 10.1111/cns.12270. (abstract)
  43. Mirza FJ, Zahid S, Holsinger RMD. Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action. Molecules. 2023. PMID 36903551. DOI 10.3390/molecules28052306. (mixed)
  44. Monsen RE, Herlofson BB, Gay C, et al.. A mouth rinse based on a tea solution of Salvia officinalis for oral discomfort in palliative cancer care: a randomized controlled trial.. Support Care Cancer. 2021. PMID 33586003. DOI 10.1007/s00520-021-06021-2. (abstract)
  45. Moradi M, Ghavami V, Niazi A, et al.. The Effect of Salvia Officinalis on Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis.. Int J Community Based Nurs Midwifery. 2023. PMID 37489230. DOI 10.30476/IJCBNM.2023.97639.2198. (abstract)
  46. Mutluay Yayla E, Izgu N, Ozdemir L, et al.. Sage tea-thyme-peppermint hydrosol oral rinse reduces chemotherapy-induced oral mucositis: A randomized controlled pilot study.. Complement Ther Med. 2016. PMID 27515877. DOI 10.1016/j.ctim.2016.05.010. (abstract)
  47. National Institute of Child Health and Human Development (NIH). Sage. Drugs and Lactation Database (LactMed). LactMed (NCBI Bookshelf). 2025. PMID 30000875. (abstract)
  48. Orhan I, Kartal M, Kan Y et al.. Activity of essential oils and individual components against acetyl- and butyrylcholinesterase. Z Naturforsch C J Biosci. 2008. PMID 18810999. DOI 10.1515/znc-2008-7-813. (in-vitro)
  49. Pelkonen O, Abass K, Wiesner J. Thujone and thujone-containing herbal medicinal and botanical products: toxicological assessment. Regul Toxicol Pharmacol. 2013. PMID 23201408. DOI 10.1016/j.yrtph.2012.11.002. (mixed)
  50. Perry NS, Houghton PJ, Jenner P, et al.. Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo.. Phytomedicine. 2002. PMID 11926204. DOI 10.1078/0944-7113-00082. (abstract)
  51. Pitarokili D, Couladis M, Petsikos-Panayotarou N et al.. Composition and antifungal activity on soil-borne pathogens of the essential oil of Salvia sclarea from Greece. J Agric Food Chem. 2002. PMID 12405762. DOI 10.1021/jf020422n. (in-vitro)
  52. Raal A, Orav A, Arak E. Composition of the essential oil of Salvia officinalis L. from various European countries.. Nat Prod Res. 2007. PMID 17487611. DOI 10.1080/14786410500528478. (abstract)
  53. Radulović NS, Genčić MS, Stojanović NM et al.. Toxic essential oils. Part V: Behaviour modulating and toxic properties of thujones and thujone-containing essential oils of Salvia officinalis L., Artemisia absinthium L., Thuja occidentalis L. and Tanacetum vulgare L.. Food Chem Toxicol. 2017. PMID 28472675. DOI 10.1016/j.fct.2017.04.044. (abstract)
  54. Rahte S, Evans R, Eugster PJ et al.. Salvia officinalis for hot flushes: towards determination of mechanism of activity and active principles.. Planta Med. 2013. PMID 23670626. DOI 10.1055/s-0032-1328552. (abstract)
  55. Rau O, Wurglics M, Paulke A et al.. Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Med. 2006. PMID 16858665. DOI 10.1055/s-2006-946680. (in-vitro)
  56. Rivera EM, Cid MP, Zunino P et al.. Central α- and β-thujone: similar anxiogenic-like effects and differential modulation on GABAA receptors in neonatal chicks.. Brain Res. 2014. PMID 24486357. DOI 10.1016/j.brainres.2014.01.039. (abstract)
  57. Romo Vaquero M, García Villalba R, Larrosa M et al.. Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats. Mol Nutr Food Res. 2013. PMID 23625681. DOI 10.1002/mnfr.201300052. (animal)
  58. Sabry MM, Abdel-Rahman RF, El-Shenawy SM et al.. Estrogenic activity of Sage (Salvia officinalis L.) aerial parts and its isolated ferulic acid in immature ovariectomized female rats.. J Ethnopharmacol. 2022. PMID 34499963. DOI 10.1016/j.jep.2021.114579. (abstract)
  59. Savelev S, Okello E, Perry NS, et al.. Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil.. Pharmacol Biochem Behav. 2003. PMID 12895684. DOI 10.1016/s0091-3057(03)00125-4. (abstract)
  60. Schapowal A, Berger D, Klein P et al.. Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial.. Eur J Med Res. 2009. PMID 19748859. DOI 10.1186/2047-783x-14-9-406. (abstract)
  61. Scholey AB, Tildesley NT, Ballard CG, et al.. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers.. Psychopharmacology (Berl). 2008. PMID 18350281. DOI 10.1007/s00213-008-1101-3. (abstract)
  62. Sá CM, Ramos AA, Azevedo MF et al.. Sage tea drinking improves lipid profile and antioxidant defences in humans. Int J Mol Sci. 2009. PMID 19865527. DOI 10.3390/ijms10093937. (human)
  63. Thamm I, Tiefenbacher K, Rychlik M. Quantification of α-Thujone and Its Metabolites in Human Urine after Consumption of a Sage Infusion Using Stable Isotope Dilution Assays.. Toxins (Basel). 2018. PMID 30513900. DOI 10.3390/toxins10120511. (abstract)
  64. Tober C, Schoop R. Modulation of neurological pathways by Salvia officinalis and its dependence on manufacturing process and plant parts used.. BMC Complement Altern Med. 2019. PMID 31196061. DOI 10.1186/s12906-019-2549-x. (abstract)
  65. Tundis R, Leporini M, Bonesi M et al.. Salvia officinalis L. from Italy: A Comparative Chemical and Biological Study of Its Essential Oil in the Mediterranean Context. Molecules. 2020. PMID 33321838. DOI 10.3390/molecules25245826. (in-vitro)
  66. US Food and Drug Administration (via eCFR). Code of Federal Regulations Title 21, section 182.10: spices and other natural seasonings and flavorings. 21 CFR 182.10. 2025. (summary-only)
  67. Usano-Alemany J, Palá-Paúl J, Rodríguez MS et al.. Chemical description and essential oil yield variability of different accessions of Salvia lavandulifolia. Nat Prod Commun. 2014. PMID 24689309. (in-vitro)
  68. Wake G, Court J, Pickering A et al.. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol. 2000. PMID 10687867. DOI 10.1016/s0378-8741(99)00113-0. (in-vitro)
  69. Walch SG, Kuballa T, Stühlinger W et al.. Determination of the biologically active flavour substances thujone and camphor in foods and medicines containing sage (Salvia officinalis L.).. Chem Cent J. 2011. PMID 21777420. DOI 10.1186/1752-153X-5-44. (abstract)
  70. Walch SG, Lachenmeier DW, Kuballa T et al.. Holistic Control of Herbal Teas and Tinctures Based on Sage (Salvia officinalis L.) for Compounds with Beneficial and Adverse Effects using NMR Spectroscopy.. Anal Chem Insights. 2012. PMID 22493561. DOI 10.4137/ACI.S8946. (abstract)
  71. Weishaupt R, Buchkov A, Kolev E, et al.. Reduction of Viral Load in Patients with Acute Sore Throats: Results from an Observational Clinical Trial with Echinacea/Salvia Lozenges.. Complement Med Res. 2023. PMID 36889292. DOI 10.1159/000530017. (abstract)
  72. Wightman EL, Jackson PA, Spittlehouse B, et al.. The Acute and Chronic Cognitive Effects of a Sage Extract: A Randomized, Placebo Controlled Study in Healthy Humans.. Nutrients. 2021. PMID 33466627. DOI 10.3390/nu13010218. (abstract)
  73. Wilfried D, Nina CDG, Silvia B. Effectiveness of Menosan® Salvia officinalis in the treatment of a wide spectrum of menopausal complaints. A double-blind, randomized, placebo-controlled, clinical trial.. Heliyon. 2021. PMID 33615001. DOI 10.1016/j.heliyon.2021.e05910. (abstract)
  74. Zeidabadi A, Yazdanpanahi Z, Dabbaghmanesh MH, et al.. The effect of Salvia officinalis extract on symptoms of flushing, night sweat, sleep disorders, and score of forgetfulness in postmenopausal women.. J Family Med Prim Care. 2020. PMID 32318472. DOI 10.4103/jfmpc.jfmpc_913_19. (abstract)
  75. . EMA/HMPC: European Union herbal monograph on Salvia officinalis L., folium (EMA/HMPC/277152/2015) and Final assessment report on Salvia officinalis L., folium and aetheroleum (EMA/HMPC/150801/2015). . . (full-text)
  76. . GBIF Backbone: Salvia apiana Jeps. (usageKey 2927016). . . (full-text)
  77. . GBIF Backbone: Salvia lavandulifolia Spreng. (usageKey 7948017). . . (full-text)
  78. . GBIF Backbone: Salvia miltiorrhiza Bunge (usageKey 7308369). . . (full-text)
  79. . GBIF Backbone: Salvia officinalis L. (usageKey 2927004). . . (full-text)
  80. . GBIF Backbone: Salvia sclarea L. (usageKey 2927000). . . (full-text)
  81. . NCBI Taxonomy: Salvia officinalis (taxid 38868) and related Salvia species. . . (full-text)
  82. . PubChem PUG REST: compound lookups by name (CIDs and molecular formulae). . . (full-text)

Where to buy

Check the label first. Whatever you buy, look for these:

  • The herb is the first or only ingredient
  • Organic or lab-tested if that matters to you
  • Loose leaf or tea bags, and how long they have been stored
  • If you take medicines or are pregnant, ask a pharmacist about the herb first

Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.

Browse Sage on Amazon
Amazon · Several brands to compare
Shop Sage tea on Amazon

Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.

Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.